{
  "title": "Large language models completely understand molecular characteristics of squamous cervical cancer",
  "url": "https://openalex.org/W4378672938",
  "year": 2023,
  "authors": [
    {
      "id": "https://openalex.org/A5083907893",
      "name": "Chaoyang Sun",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5043782446",
      "name": "Weizhi Zhang",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Nanjing University",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5101899494",
      "name": "Funian Lu",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5015584107",
      "name": "Tianyu Qin",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5046910965",
      "name": "Yujie Gou",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5013167986",
      "name": "Ensong Guo",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5019144745",
      "name": "Di Peng",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5100425706",
      "name": "Li Zhang",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5034030001",
      "name": "Bin Yang",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5100330137",
      "name": "Si Liu",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5100325130",
      "name": "Cheng Han",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5102289651",
      "name": "Shanshan Fu",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5100722258",
      "name": "Kun Song",
      "affiliations": [
        "Qilu Hospital of Shandong University"
      ]
    },
    {
      "id": "https://openalex.org/A5060604602",
      "name": "Bairong Xia",
      "affiliations": [
        "University of Science and Technology of China"
      ]
    },
    {
      "id": "https://openalex.org/A5034833317",
      "name": "Dongling Zou",
      "affiliations": [
        "Chongqing Cancer Hospital",
        "Chongqing University"
      ]
    },
    {
      "id": "https://openalex.org/A5026629580",
      "name": "Yuanming Shen",
      "affiliations": [
        "Women's Hospital, School of Medicine, Zhejiang University"
      ]
    },
    {
      "id": "https://openalex.org/A5030342643",
      "name": "He Huang",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5002176879",
      "name": "Shengtao Zhou",
      "affiliations": [
        "State Key Laboratory of Biotherapy",
        "Sichuan University"
      ]
    },
    {
      "id": "https://openalex.org/A5066013730",
      "name": "Cunzhong Yuan",
      "affiliations": [
        "Qilu Hospital of Shandong University"
      ]
    },
    {
      "id": "https://openalex.org/A5000956644",
      "name": "Yao Shu",
      "affiliations": [
        "Qilu Hospital of Shandong University"
      ]
    },
    {
      "id": "https://openalex.org/A5071073892",
      "name": "Yanan Pi",
      "affiliations": [
        "University of Science and Technology of China"
      ]
    },
    {
      "id": "https://openalex.org/A5061117828",
      "name": "Shuxiang Wang",
      "affiliations": [
        "University of Science and Technology of China"
      ]
    },
    {
      "id": "https://openalex.org/A5100634098",
      "name": "Wenjuan Chen",
      "affiliations": [
        "Chongqing Cancer Hospital",
        "Chongqing University"
      ]
    },
    {
      "id": "https://openalex.org/A5100439432",
      "name": "Haixia Wang",
      "affiliations": [
        "Chongqing Cancer Hospital",
        "Chongqing University"
      ]
    },
    {
      "id": "https://openalex.org/A5058076881",
      "name": "Zhong Lin",
      "affiliations": [
        "Chongqing Cancer Hospital",
        "Chongqing University"
      ]
    },
    {
      "id": "https://openalex.org/A5100716334",
      "name": "Li Yuan",
      "affiliations": [
        "Chongqing Cancer Hospital",
        "Chongqing University"
      ]
    },
    {
      "id": "https://openalex.org/A5035074815",
      "name": "Baogang Wen",
      "affiliations": [
        "Chongqing Cancer Hospital",
        "Chongqing University"
      ]
    },
    {
      "id": "https://openalex.org/A5101901590",
      "name": "Siqi Yang",
      "affiliations": [
        "Chongqing Cancer Hospital",
        "Chongqing University",
        "Women's Hospital, School of Medicine, Zhejiang University"
      ]
    },
    {
      "id": "https://openalex.org/A5065260000",
      "name": "Ting Wan",
      "affiliations": [
        "Sun Yat-sen University",
        "Sun Yat-sen University Cancer Center"
      ]
    },
    {
      "id": "https://openalex.org/A5114259004",
      "name": "Junpeng Fan",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5032931020",
      "name": "Yu Fu",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5101473353",
      "name": "Dan Liu",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5008366921",
      "name": "Rourou Xiao",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5100736112",
      "name": "Chi Zhang",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5058312928",
      "name": "Yuxiang Wei",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5101440712",
      "name": "Wenju Peng",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5072540946",
      "name": "Xinhe Huang",
      "affiliations": [
        "Huazhong University of Science and Technology"
      ]
    },
    {
      "id": "https://openalex.org/A5100335565",
      "name": "Beibei Wang",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5089146826",
      "name": "Peng Wu",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5071719406",
      "name": "Beihua Kong",
      "affiliations": [
        "Qilu Hospital of Shandong University"
      ]
    },
    {
      "id": "https://openalex.org/A5005221518",
      "name": "Gordon B. Mills",
      "affiliations": [
        "Oregon Health & Science University"
      ]
    },
    {
      "id": "https://openalex.org/A5037247754",
      "name": "Ding Ma",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5100389288",
      "name": "Gang Chen",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Tongji Hospital"
      ]
    },
    {
      "id": "https://openalex.org/A5052691524",
      "name": "Yu Xue",
      "affiliations": [
        "Huazhong University of Science and Technology",
        "Nanjing University"
      ]
    }
  ],
  "references": [
    "https://openalex.org/W3128646645",
    "https://openalex.org/W6736821290",
    "https://openalex.org/W2168083201",
    "https://openalex.org/W3007332248",
    "https://openalex.org/W1969854832",
    "https://openalex.org/W3173096232",
    "https://openalex.org/W2987444072",
    "https://openalex.org/W2575837388",
    "https://openalex.org/W4212765645",
    "https://openalex.org/W4286500588",
    "https://openalex.org/W4318071656",
    "https://openalex.org/W6800905727",
    "https://openalex.org/W2092447073",
    "https://openalex.org/W4319078991",
    "https://openalex.org/W2782709892",
    "https://openalex.org/W3036882247",
    "https://openalex.org/W2023410485",
    "https://openalex.org/W2904296893",
    "https://openalex.org/W2925757443",
    "https://openalex.org/W2981195015",
    "https://openalex.org/W3088838661",
    "https://openalex.org/W2216217499",
    "https://openalex.org/W3174142698",
    "https://openalex.org/W2803806527",
    "https://openalex.org/W4206221507",
    "https://openalex.org/W1981417550",
    "https://openalex.org/W2048018833",
    "https://openalex.org/W3082390367",
    "https://openalex.org/W2555337234",
    "https://openalex.org/W3080531908",
    "https://openalex.org/W2904128410",
    "https://openalex.org/W2466366317",
    "https://openalex.org/W3113820494",
    "https://openalex.org/W2939856144",
    "https://openalex.org/W2954862062",
    "https://openalex.org/W2091512988",
    "https://openalex.org/W3016135526",
    "https://openalex.org/W2887249435",
    "https://openalex.org/W3082181271",
    "https://openalex.org/W2131856634",
    "https://openalex.org/W2395887422",
    "https://openalex.org/W3041219630",
    "https://openalex.org/W2982402173",
    "https://openalex.org/W6772426556",
    "https://openalex.org/W3003709606",
    "https://openalex.org/W2760946358",
    "https://openalex.org/W2772723798",
    "https://openalex.org/W4323532376",
    "https://openalex.org/W3106120778",
    "https://openalex.org/W6755447157",
    "https://openalex.org/W2127640118",
    "https://openalex.org/W3004434748",
    "https://openalex.org/W2119180969",
    "https://openalex.org/W6786479588",
    "https://openalex.org/W6684826817",
    "https://openalex.org/W3104739447",
    "https://openalex.org/W3113044156",
    "https://openalex.org/W6601067093",
    "https://openalex.org/W6602046083",
    "https://openalex.org/W6600946615",
    "https://openalex.org/W6822889753",
    "https://openalex.org/W6601584866",
    "https://openalex.org/W2043274355",
    "https://openalex.org/W3081006013",
    "https://openalex.org/W3128999657",
    "https://openalex.org/W1999574084",
    "https://openalex.org/W2898909792",
    "https://openalex.org/W2803760365",
    "https://openalex.org/W4309908811",
    "https://openalex.org/W4386725846",
    "https://openalex.org/W4309999671",
    "https://openalex.org/W2115462905",
    "https://openalex.org/W2169456326",
    "https://openalex.org/W4318263917",
    "https://openalex.org/W2069089843",
    "https://openalex.org/W3099183222",
    "https://openalex.org/W2999681746",
    "https://openalex.org/W2100802828",
    "https://openalex.org/W3044996171",
    "https://openalex.org/W3162966461",
    "https://openalex.org/W4327550249",
    "https://openalex.org/W2089350319",
    "https://openalex.org/W2558534012",
    "https://openalex.org/W3000075214",
    "https://openalex.org/W4317476671",
    "https://openalex.org/W2898789672",
    "https://openalex.org/W3147368647",
    "https://openalex.org/W2103441770",
    "https://openalex.org/W4226278401",
    "https://openalex.org/W2952952194",
    "https://openalex.org/W4322757547",
    "https://openalex.org/W2611332446",
    "https://openalex.org/W2329939076",
    "https://openalex.org/W4206722756",
    "https://openalex.org/W4319083882",
    "https://openalex.org/W2092123736",
    "https://openalex.org/W2750092411",
    "https://openalex.org/W1986656413",
    "https://openalex.org/W2951821937",
    "https://openalex.org/W4319793302",
    "https://openalex.org/W2917858269",
    "https://openalex.org/W2782454362",
    "https://openalex.org/W4200038346",
    "https://openalex.org/W2212776653",
    "https://openalex.org/W1998675253",
    "https://openalex.org/W3217269355",
    "https://openalex.org/W4200608270",
    "https://openalex.org/W2950595506",
    "https://openalex.org/W3200120773",
    "https://openalex.org/W4321371665",
    "https://openalex.org/W2128021317",
    "https://openalex.org/W2098754388",
    "https://openalex.org/W2117513900",
    "https://openalex.org/W1976588449",
    "https://openalex.org/W3033054761",
    "https://openalex.org/W2559588208",
    "https://openalex.org/W4231936261",
    "https://openalex.org/W2964245665",
    "https://openalex.org/W2140883620",
    "https://openalex.org/W3175627440"
  ],
  "abstract": "<title>Abstract</title> Squamous cervical cancer (SCC) is a major cause of death in women, yet its molecular characteristics are poorly understood. Here, we profiled histopathological and molecular alterations in SCC, and used large language models (LLMs) for interpretation, reasoning, and understanding of multi-modal data. We implemented an immersive-knowledge prompting (iKLP) strategy to trigger LLMs, which interpreted 17.8%-20.3% of omic alterations known to be associated with cancer. Also, the emergence of cross-disciplinary reasoning in LLMs helped for interpreting phenotypic effects of SCC molecular alterations, exemplified by a prognostic biomarker HRG, and targetable kinases, CDK18 and CDK9. With experimental validations, LLM-reasoning showed &gt;2-fold increased confidence for 68.5% of analyzed molecules. Strikingly, LLMs understood the information flow of cell-cell communications, and uncovered a CDK18-mediated immune escaping axis in orchestrating the crosstalk of malignant, immune, and niche cells. We anticipate that LLMs can be used for completely distinguishing between knowns and unknowns in any scientific problems.",
  "full_text": "Large language models completely understand\nmolecular characteristics of squamous cervical\ncancer\nChaoyang Sun  (  suncydoctor@gmail.com )\nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nhttps://orcid.org/0000-0003-2469-1638\nWeizhi Zhang \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nFunian Lu \nDepartment of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University\nof Science and Technology\nTianyu Qin \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nYujie Gou \nKey Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and\nTechnology, Huazhong University of Science and Technology\nEnsong Guo \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nhttps://orcid.org/0000-0002-7388-4324\nDi Peng \nHuazhong University of Science and Technology https://orcid.org/0000-0002-1249-3741\nLi Zhang \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nBin Yang \nDepartment of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University\nof Science and Technology https://orcid.org/0000-0002-6218-2773\nSi Liu \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nCheng Han \nKey Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and\nTechnology, Huazhong University of Science and Technology\nShanshan Fu \nCollege of Life Science and Technology, Huazhong University of Science and Technology\nKun Song \nhttps://orcid.org/0000-0001-6110-2770\nBairong Xia \nThe First A\u0000liated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and\nTechnology of China\nDongling Zou \nChongqing University Cancer Hospital\nYuanming Shen \nWomen's Hospital, Zhejiang University School of Medicine\nHe Huang \nSun Yat-sen University cancer center\nShengtao Zhou \nSichuan University https://orcid.org/0000-0001-8322-5536\nCunzhong Yuan \nQilu Hospital of Shandong University\nYao Shu \nQilu Hospital of Shandong University\nYanan Pi \nThe First A\u0000liated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and\nTechnology of China\nShuxiang Wang \nThe First A\u0000liated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and\nTechnology of China\nWenjuan Chen \nChongqing University Cancer Hospital\nHaixia Wang \nChongqing University Cancer Hospital\nLin Zhong \nChongqing University Cancer Hospital\nLi Yuan \nChongqing University Cancer Hospital\nBaogang Wen \nChongqing University Cancer Hospital\nSiqi Yang \nWest China Second Hospital, Sichuan University and Collaborative Innovation Center\nTing Wan \nSun Yat-sen University cancer center\nJunpeng Fan \nDepartment of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University\nof Science and Technology https://orcid.org/0000-0002-9413-408X\nYu Fu \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nDan Liu \nKey Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and\nTechnology, Huazhong University of Science and Technology https://orcid.org/0000-0002-8376-7287\nRourou Xiao \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nChi Zhang \nCollege of Life Science and Technology, Huazhong University of Science and Technology\nYuxiang Wei \nKey Laboratory of Molecular Biophysics of Ministry of Education, College of Life Science and\nTechnology, Huazhong University of Science and Technology\nWenju Peng \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nXinhe Huang \nCollege of Life Science and Technology, Huazhong University of Science and Technology\nBeibei Wang \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nPeng Wu \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nhttps://orcid.org/0000-0003-4498-7663\nBeihua Kong \nShandong University https://orcid.org/0000-0002-1627-1150\nGordon Mills \nOregon Health & Science University https://orcid.org/0000-0002-0144-9614\nDing Ma \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nGang Chen \nTongji Hospital, Tongji Medical College, Huazhong University of Science and Technology\nhttps://orcid.org/0000-0002-8320-6594\nYu Xue \nHuazhong University of Science and Technology https://orcid.org/0000-0002-9403-6869\nBiological Sciences - Article\nKeywords:\nPosted Date: May 30th, 2023\nDOI: https://doi.org/10.21203/rs.3.rs-2855719/v1\nLicense:   This work is licensed under a Creative Commons Attribution 4.0 International License.  \nRead Full License\nAdditional Declarations: There is NO Competing Interest.\nLarge language models completely understand molecular\ncharacteristics of squamous cervical cancer\nWeizhi Zhang1,2,3,*, FunianLu1,*,Tianyu Qin1,*,YujieGou 2,*, EnsongGuo1,Di\nPeng2,Li Zhang1, BinYang1, Si Liu1, ChengHan2, ShanshanFu2, Kun\nSong4,5,6,BairongXia 7,Dongling Zou8,YuanmingShen 9,He Huang10,\nShengtaoZhou11, CunzhongYuan4,5,6,YaoShu 4,5,6,YananPi 7, Shuxiang\nWang7, WenjuanChen8,Haixia Wang8, LinZhong8,LiYuan 8,Baogang Wen8,\nSiqiYang9,TingWan 10,JunpengFan 1,YuFu 1,Dan Liu2, RourouXiao1, Chi\nZhang2,YuxiangWei 2,Wenju Peng1, XinheHuang2, BeibeiWang1,PengWu 1,\nBeihuaKong4,5,6,GordonB. Mills12, Ding Ma1,13#,GangChen 1,#,YuXue 2,3,#,\nChaoyangSun1,#\n1National Clinical ResearchCenter forGynecology andObstetrics andCancer\nBiology Research Center, Tongji Hospital, Tongji Medical College, Huazhong\nUniversity ofScienceandTechnology,Wuhan430030,China\n2Department of Bioinformatics and Systems Biology, MOE Key Laboratory of\nMolecular Biophysics, Hubei Bioinformatics and Molecular Imagin g Key\nLaboratory, College of Life Science and Technology, Huazhong University of\nScienceandTechnology,Wuhan430074,China\n3Nanjing University Institute of Artificial Intelligence Biomedicine, Nanjing,\n210031,China\n4Department of Obstetrics and Gynecology, Qilu Hospital of Shand ong\nUniversity,Jinan250000,China\n5Gynecology Oncology Key Laboratory, Qilu Hospital of ShandongUniversity,\nJinan,250000China\n6DivisionofGynecologyOncology,QiluHospitalofShandongUnive rsity,Jinan,\n250000China\n7Department of Gynecology, The First Affiliated Hospital of USTC, Division of\nLife Sciences and Medicine, University of Science and Technology ofChina,\nHefei230031,China\n8Chongqing Key Laboratory of Translational Research for Cancer Metastasis\nand Individualized Treatment, Chongqing University Cancer H ospital,\nChongqing400030,China\n9Department of Gynecologic Oncology,Women's Hospital, Zhejiang University\nSchoolof Medicine,Hangzhou310000,China\n10Department of Gynecologic Oncology, SunYat-sen University cancercenter,\n651DongfengEastRoad,Guangzhou510060,China\n11Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects\nand Related Diseases of Women and Children of MOE and State Key\nLaboratory of Biotherapy, West China Second Hospital, Sichuan University\nandCollaborative InnovationCenter,Chengdu, 610000,Chi na\n12Division of Oncological Sciences, Knight Cancer Institute, Oregon Health\nandSciencesUniversity,Portland,OR 97201, USA\n13Leadcontact\n*Theseauthors contributedequally\n#Theseauthorscontributedequally\n*Correspondence: dingma424@126.com (D.M.), tjchengang@hust. edu.cn\n(G.C.),xueyu@hust.edu.cn (Y.X.), suncydoctor@gmail.com(C.S.)\nSUMMARY\nSquamous cervical cancer (SCC) is a major cause of death in women, yet its\nmolecular characteristics are poorly understood. Here, we profil ed\nhistopathological and molecular alterations in SCC, and used large language\nmodels (LLMs)for interpretation, reasoning, and understanding of multi-modal\ndata. We implemented an immersive-knowledge prompting (iKLP) strategy to\ntrigger LLMs, which interpreted 17.8%-20.3% of omic alterations known to be\nassociatedwith cancer.Also, the emergenceof cross-disciplinary reasoning in\nLLMs helped for interpreting phenotypic effects of SCC molecular alterations,\nexemplified by a prognostic biomarker HRG, and targetable kinases, CDK18\nand CDK9. With experimental validations, LLM-reasoning showed >2-fold\nincreased confidence for 68.5% of analyzed molecules. Strikingly, LL Ms\nunderstood the information flow of cell-cell communications, anduncovered a\nCDK18-mediated immune escaping axis in orchestrating the crosstalk of\nmalignant, immune, and niche cells. We anticipate that LLMs can beused for\ncompletely distinguishing between knowns and unknowns in any scientific\nproblems.\nHighlights\n With prompt engineering, LLMs interpreted 17.8%-20.3% of S CC\nmolecularalterationsknown tobeassociatedwith cancer.\n LLM-emergent cross-disciplinary reasoning facilitated in uncover ing\nhistopathologicalphenotypic effectsofSCC molecularsignatur es.\n Our following experiments significantly enhanced the confiden ce of\nLLM-reasoningwith>2-fold for68.5%of analyzed molecules.\n LLM-aided understanding revealed a CDK18-mediated immune escaping\naxis within crosstalkofmalignant, immune,andnichecells.\nINTRODUCTION\nHuman cervical cancer, which is caused by high-risk human papillomavirus\n(hr-HPV) infection, is the fourth leading cause of cancer death inwomen,\nresulting in 342,000 deaths worldwide in 20201. Squamous cervical cancer\n(SCC) that arises in the ectocervix accounts for 75-80% of all cervical cancer\ncases2,3. Treatment approaches and outcomes for SCC are highly dependent\non disease stage at diagnosis. Although the prognosis of localized SCC is\nrelatively favorable, the 5-year survival rate of late-stage, metastatic, or\nrecurrent SCC is only 16.5%, with the median survival time of 8-13 months4,5.\nThere is thus an urgent need to improve our understanding of phenotypic and\nmolecular alterations leading to effective new therapeutic options, especially\nforadvancedSCC.\nSCC is notable for substantial inter- and intra-tumor heterogeneity in both\nphenotypicandmolecularcompositions 6,7,whichcontributetodrugresistance,\nmetastasis, and tumor relapse8,9. At the molecular level, the Cancer Genome\nAtlas (TCGA) research network profiled genomic and transcripto mic\nalterations in 178 SCC tumors, and identified numerous molecular signatures,\nsuch as a frequently mutated oncogenePIK3CA 10. On the other hand, the\nstate-of-the-art (SOTA) deep learning, such as convolutional neural network\n(CNN), has been employed to accurately detect or diagnose cervicalcancer\nfrom histopathological images11,12. However, both phenotypic and molecular\ncharacteristics ofSCC were poorly interpreted,reasonedandunderstood.\nRecent advances in the next-generation artificial intelligen ce (AI)\ntechnology, namely large language models (LLMs), such as genera tive\npre-trained transformer (GPT) and its variants, may dramatically accelerate\nbreakthrough innovations in many disciplines13,14. Since 2018, OpenAI have\nmade several updates from GPT-1 to GPT-3 for artificial intell igence\ngeneratedcontent(AIGC) 15.AlthoughtheparametersofGPT-3reachedupto\n175 billion, its answers were still far from comparable to the chain-of-thought\n(CoT)fromhumans 16.Withthestrategyofreinforcementlearningfromhuman\nfeedback (RLHF), instructGPT/GPT-3.5 was fine-tuned to align human\nperceptions 17,18, and its sibling model ChatGPT has become a worldwide\npopular tool for generating answers in an innovative way19. Although LLMs\nhave been successfully used for prediction of protein sequences and\nstructures 20,21, it’s not known whether LLMs can be used for other purposes\nbeyondprediction.\nIn this study, we profiled the histopathological and multi-omic landscapes\nof SCC from a cohort of 114 Chinese patients. The molecular alterations were\nidentifiedandthencompletelyinterpretedbyChatGPT,thou ghimplementation\nof an immersive-knowledge prompting (iKLP) strategy. Using iKLP, we first\ndelivered the background knowledge to ChatGPT, which then accurately\ndistinguished between knowns and unknowns, and interpreted 17.8%-20.3%\nof omic alterations known to be functional in cancer. A SOTA pipeline, deep\nlearning of cancer multi-modal data (deepCMD), was designed for SCC tumor\nsubtyping and prediction of molecules of interest (MOIs), such as potential\nbiomarker proteins and therapeutic kinases. Then, cross-disciplina ry\nreasoning of LLMs was performed to identify phenotypic effects of MOIs,\nwhereas our further experimental validations dramatically increased the\nconfidence of LLM-reasoning with >2-fold for 68.5% of tested MOIs. Together\nwith a single-cell spatial proteomics (SCSP) profiling, 29 malignant, immune\nand niche cell states were recognized. The known information flowof cell-cell\ncommunications was fully understood by ChatGPT, which reasoned ahighly\nconvincing CDK18-mediated immune escape axis through alteringthe cell\nsurface markers. Taken together, we not only completely understood known\nand unknowns of molecular characteristics in SCC, but also established a\nhuman-AI interactive paradigm that can completely address any scientific\nproblems. Of note, the emergence of cross-disciplinary reasoning inChatGPT\nindicated that the intelligent agent could not only learn and u nderstand\nhuman-like intellectual tasks, but also use its learnt knowledge to form a link\nbetween diverse disciplines, showing a strong property of artificial general\nintelligence(AGI).\nRESULTS\nA framework for complete understanding of SCC by LLMs\nIn this study, the leading LLM, ChatGPT, was used for interpret ation,\nreasoning and providing new biological insights of SCC (Figure1A). From a\nChinese cohort with detailed clinical features (CFs), the histopathological and\nmolecular profiles in tumors and paired non-tumor adjacent tissues (NATs)\nwere obtained from histopathological whole slide images (WSIs), proteomics,\nphosphoproteomics,exomics, transcriptomics, and SCSP(Figure 1B).Intotal,\nwe obtained 313 and 332 high-resolution WSIs of hematoxylin and eosin (H &\nE) staining of frozen sections of tumors and NATs from 114 SCC patients,\nrespectively. From 114 patients, we identified 1,394 differentially expressed\nproteins (DEPs), 4,598 differentially regulated p-sites (DR Ps), 1,198\ndifferentially phosphorylated proteins (DPPs), 14 frequently mutated genes\n(FMGs), and2,424differentiallyexpressedgenes(DEGs)intumo rscompared\ntoNATs (Figure S1B-F, TableS3,S4).\nTo trigger the ability of ChatGPT on efficiently answering questions, we\nimplemented a prompt engineering strategy, iKLP, by querying the biological\nfunctionsofanalteredmolecule,its associationwithcancer,andt hepathways\nit involved in (Figure 1C). In each following step, the previousanswers were\nincluded prior to the query as the background knowledge. In this way, we\nobtained 19,321 high-quality prompt-generation pairs (PGPs) for all altered\nmolecules at proteomic, phosphoproteomic and transcriptomic le vels.\nChatGPT completely distinguished knowns and unknowns, and interpreted\n17.8%-20.3% of DEPs, DPPs, and DEGs known to be associated with cancer\n(Figure 1A), with an accuracy of 52.3%-78.0% by manually checking the\npositive responses. Then, the queries were narrowed down to the background\nof cervical cancer, and the positive responding rates (P2R) were decreased to\n5.7%-8.7% (Figure 1A), indicating that the knowledge is far from saturated for\nindividual cancertypes.\nMucin-16 (MUC16/CA125) is well known cervical cancer biomarker for\nscreening or early diagnosis 22,23, and has been identified as the most\nsignificantly upregulated DEP in SCC tumors against NATs, witha logarithmic\nfold-change [log2(FC)] of 1.49 (Figure 1E,Adjusted p = 2.63E-07, Table S4A).\nUsing iKLP, ChatGPT correctly interpreted its functions as a transmembrane\nprotein to beoverexpressed in cervical cancer24, andpromotecervical cancer\nprogression potentially through multiple signaling pathways, su ch as\nWnt/β-cateninandSrc kinasesignaling 25,26 (Figure 1D).\nFrom representative tiles of WSIs, we also identified a differential imaging\ncharacteristic (DIC), “StDev_nuclei_AreaShape_MinFeretDia meter”, to be\nover-represented in SCC tumors compared to NATs. Then, we adapted iKLP,\nbyqueryingChatGTPforthemeaningofthisfeature,themeani ngofitshigher\nvalue in H & E images, and the potential relation between this feature and\nMUC16 protein expression (Figure 1E). ChatGTP interpreted that this feature\ndenotes the standard deviation (S.D.) of the minimum Feret diameter of the\nnuclei,andahighervalueofthisfeatureindicatesa higherva riationofnuclei’s\nsize and shape. Then, ChatGTP reasoned that higher MUC16 expression\nmight be correlated with a higher value of this feature in two ways (Figure 1F,\nTableS1). First, tumorregionsof SCC patientswith higherMUC16 expression\nmightbemoreheterogenouswithahighervarietyofnucleisizea ndshape 27,\nandhaveahighervalueofthisfeaturethanNATs.Alternativ ely,higherMUC16\nexpression might have greater metabolic tumor burden28, which result in a\nhigher nuclear density to increase the value of this feature in tumors against\nNATs. Based on cross-disciplinary reasoning, ChatGTP reasonably formed a\nlink between phenotypic effects and molecular alterations. Inthis study, we\nobtained 46,939 additional PGPs to reason the phenotypic effects of 72\nalteredmoleculesandsingle-cell nucleiprofileson643imagin gcharacteristics\n(TableS1).\nLLM-aided interpretation of genomic alterations in SCC\nUsing NATs as control, whole-exome sequencing (WES) analysis identified\n19,496non-redundant somatic variants of8,495 codinggenes in SCC tumors,\nincluding 17,312 single nucleotide variants (SNVs), 1,858 inser tions or\ndeletions(indels),and326multi-nucleotidevariants(MNVs) (TableS3).Intotal,\nwe identified 14 potential FMGs in SCC tumors, includingPIK3CA (22%),\nKMT2D (17%), KMT2C (13%), HUWE1 (10%), FAT1 (10%), EP300 (10%),\nNOTCH2 (8%), STK11 (7%), FBXW7 (7%), CASP8 (7%), LRP1B (6%),\nERBB3 (6%),ATRX (6%),and AR (6%)(Figure 2A).\nIt was reported that APOBEC mutagenesis induced by APOBEC cytidine\ndeaminases might be the prevalent source of mutations in cervicalcancer\n10,29,30. Consistently, we found 55 of 89 (61.8%) tumor exhibiting significant\nenrichment for the APOBEC signature (p < 0.05) (Figure 2A), supporting the\nmutationalprocessinourSCCcohortwasalsodrivenbyacellularre sponseto\nviral infections. By comparison, the mutation frequencies of FMGs identified in\nthisstudywere similartoprevious reports 10,31-34, supportingthehigh quality of\nourWESprofiling (Figure2B).\nWith the help of ChatGPT, the mutation status of 6 potential FMGs,\nincluding PIK3CA, KMT2D, FAT1, FBXW7, CASP8, and LRP1B, were\ninterpreted known to be associated with SCC, as well as downstream\npathways potentially regulated by these gene mutations (Figure 2X-X). For\nexample, ChatGPT interpreted that PIK3CA is a component of th e\nPI3K/Akt/mTOR signaling pathway that regulates cell growth, su rvival,\ndifferentiation, and motility, and demonstrated thatPIK3CA mutations occurs\nin a subset of SCC tumors 31 (Figure 2C). Then, ChatGPT appropriately\nreasoned that the PIK3CA mutation might activate the PI3K/Akt/mTOR\nsignaling pathway to influence cell cycle progression, DNA repair, and\napoptosis, and ultimately promote cell proliferation, survival , and cancer\ndevelopment 35. Also, the histone-lysine N-methyltransferase KMT2D was\ninterpreted as a modifier to methylate the lysine 4 of histone H3(H3K4) and\nactive gene transcription36, and loss-of-function mutations inKMT2D reduce\nits methyltransferase activity to alter immune responses37and increase the\nsusceptibility to HPV infection in cervical cancer38 (Figure 2D). The functional\nimpacts of the mutations in the remaining 4 FMGs were also well interpreted\nandreasonedbyChatGPT (Figure 2E-H).\nClassification of SCC patients into clinically interpretable subtypes\nThe aim of molecular subtyping is the classification of patients into clinically\nrelevantclusters 10.IncontrasttouseofasingleCF,overallsurvival(OS),here\nwe applied 16 CFs tightly associated with SCC outcomes (Table S2). Due to\nthe inefficiency of the unsupervised clustering, we hypothesized that CFs and\nmolecular or imaging subtypes that are able to predict outcomes should be\nconsistent with each other, and such a consistency could be iteratively\noptimized. Based on this hypothesis, we implemented a subtypingmodule of\ndeepCMD, which classified SCC tumors into clinically relevant subtypes for\neachtypeofmulti-modal data.\nFrom the results, we found that proteomic subtypes had the strongest\nclinical relevance with the CF subtypes ( p = 0.0048), followed by\nphosphoproteomic subtypes (p = 0.0149). The 3 proteomic subtypes could be\nunambiguously designated as keratin-high (S-I), keratin-low ( S-II), and\ninflammation/complement (S-III) subtypes (Figure 3B). S-II I tumors were\nassociated with advanced FIGO stage (p = 6.07E-07) and larger tumor sizes\n(p = 0.0007), both of which are correlated with a worse patient outcome\n(Figure 3B).A number of keratin proteins, including KRT5, KRT4and KRT20,\nwere markedly up-regulated in S-I tumors and down-regulatedin S-II tumors,\nsupporting the classification of keratin-high and keratin-low subtypes. Notably,\nthe degrees of keratinization quantified by WSI were highest in S-I and lowest\nin S-II (Figure 3C). In S-II, many ribosomal proteins such as RPL10, RPS6,\nRPL17, RPS24, RPS4X, RPS15, RPL10L, and RPS4Y2 were up-regulated,\nconsistent with enhanced protein translation in this subtype (Figure 3B). For\nproteomic subtypes, Gene Ontology (GO)-based enrichment analyse s of\nsubtype-specific DEPs demonstrated that both viral transcriptio n and\ntranslation processes are particularly active in the keratin-high subtypes\n(Figure S2D). Tumors in S-III were characterized by higher expression of\nmembers of the complement cascade (C9, C8A, C8G, CP, C5, C3, C8B, C6,\nC7,CFB,andMASP-1),andinflammation-relatedproteins (A POH,PGLYRP2,\nand LBP). Factors that trigger activation of the complement pathway (IGHG2,\nIGHG4, PLG, HRG, F2, PLGLA, PLGLB1, and KNG1) were also upregulated\nin S-III (Figure 3B). Moreover, relatively high expression ofmembers of serine\nprotease inhibitor (SERPIN) proteins might inhibit lysosomal cell death39 in\nS-III tumors. We quantified a significantly higher level of immune infiltration in\nS-IIIcomparedwith theothertwo subtypes(Figure3C, D).\nAll subtype-specific DEPs, DPPs and DEGs were completely interpreted\nby ChatGPT, as well as potential pathways they involved in (Table S1). For\nexample, an S-I-specific DEP, desmoglein-3 (DSG3) was interpreted as a cell\nadhesion molecule that is upregulated in SCC40, and might promote cancer\ngrowth and spread through modulating multiple signaling pathways such as\nPI3K/AKT and MAPK/ERK41,42 (Figure 3E). The 40S ribosomal protein S6\n(RPS6), an S-I-specific DEP, was interpreted to be involved in regulating\ntranslationalinitiationandelongation,anditsoverexpressi onincervicalcancer\nmight be associated with poor prognosis43. The major pathway that RPS6\ninvolved in is the PI3K/Akt/mTOR pathway, in which RPS6 interactswith and\nactivates mTOR to promote protein synthesis and cell growth20.Alternatively,\nRPS6 could also inhibit the tumor suppressive function of TP53 to increased\nrisk of tumorigenesis 44 (Figure 3E). Taken together, the superiority of\nChatGPT in literature searching and logic presentation libera tes human\nscientistsfromtime-consumingandtediousdocumentwork.\nPhenotypic effects of potential biomarker proteins in SCC\nNext, we sought to identify new tumor- and subtype-specific prot ein\nbiomarkers. Considering that 1,394 DEPs were identified, it was not possible\nto validate each candidate.Acombination of proteins is likely to be a stronger\npredictorthananindividualprotein.However,individualp roteinsindispensable\nfor the predictive value of the combinations might be useful biomarkers for\nfurther clinical application. Thus, we designed a biomarker modul e of\ndeepCMD to predict tumor-specific or subtype-specific protein combinations,\nbasedonthehighestareaunderthecurve (AUC)values (Figure 4A ).\nFor the top 10 tumor-specific combinations, the mean AUC value ofthe\ncombinations was 0.9654 (Figure 3B). For the 33 proteins in th ese\ncombinations, we hypothesized that the most reliable marker biomarkers\nwould be functionally indispensable in SCC. We subsequently determined the\neffect of knocking down each gene with small interfering RNAs (siRNAs)\n(Table S6) in both HeLa and SiHa cervical cancer cells, with scrambled\nsiRNAs being used as the negative control. Silencing GINS3, EPCAM,\nDHCR24, SERPINB5, ABRACL, GBP1, TAPBP, STAT1, BRI3BP, DTX3L, or\nRBM8A induced a > 1/3-fold suppression on the proliferation of HeLa and/or\nSiHacells, withatleastonesiRNA(Two-sidedt-test, p <0.05,Figure S2D,E).\nBased on immunohistochemistry (IHC), 4 out of 10 proteins, DHCR24, GBP1,\nEPCAM, and PSF3, tested with available antibodies were marked ly\nup-regulated in tumor cells compared to the normal cervix (Figure 4C, D and\nS4F).\nTop 10 combinations specific for S-I, S-II, and S-III proteomicsubtypes\ncontained 21, 31 and 42 individual proteins, respectively (Figure 3B, Figure\nS3A-C, Table S5B). We selected the most invasive S-III specific candidate\nbiomarkers, the histidine-rich glycoprotein (HRG), SEPTIN5, SERPINA4, and\nplasminogen (PLG) for IHC validation in 25 SCC tumors. IHC results showed\nnotable inter-tumor heterogeneity yet with a clear co-expressi on pattern\n(Figure 4E, Figure S3G). Based on the high expression of HRG in the 25\ntumors (Figure 4E), we tested HRG expression in a second cohort containing\n160 SCC patients and confirmed that HRG is associated with advanced FIGO\nstage (Figure 4F, G). Moreover, we verified that HRG protein expression\npredicted a worse OS in a third independent cohort of 115 SCCs (Figure 4H,\nlog-rankp<0.05).\nWe stratified the patients using median as the cutoff for HRG protein\nexpression, and identified “StDev_nuclei_AreaShape_FormFa ctor” as an\nenriched DIC in HRG highly expressed tumors, from representativetiles of\nWSIs (Figure S3H,p = 0.0102). Using iKLP mentioned above (Figure 1C),\nChatGPT interpreted that this feature measures the S.D. of “Form Factor”, a\nshapedescriptor,ofnuclei,andahighervalueofthisfeaturein dicatesahigher\natypia or variability of nuclear shape, as a hallmark of malignancy. Then,\nChatGPT reasoned that that HRG is involved in multiple biological processes\nsuch as hemostasis, immune response, and cell adhesion, and its higher\nexpression might be associated with increased cell adhesion or altere d\nsignaling pathways45, and result in morphological changes in nuclei with a\nhigher value of this feature. Thus, the phenotypic effect of HRG protein\nexpressionchanges wasclearly interpretedandreasonedbyChatG PT.\nTo quantitatively exhibit the importance of our experimental efforts, we\nqueried ChatGPT on the relations between candidate biomarkerproteins and\nSCC, with or without inputting our experimental results. Fromthe results, we\nfound that 66.6% of the 36 biomarkers with experimental validations could\nachieve >2-fold increased confidence of LLM-reasoning (Figure 4J), implying\nthe key role of human scientists in providing new biological insights, together\nwith the help of LLMs. The phenotypic efforts of 35 other candidate biomarker\nproteinswere alsoreasonedbyChatGPT(TableS1).\nIntepretation and reasoning of theareputic kinases\nProtein kinases (PKs) are altered and dysfunctional in different tumors\nresulting in the dysregulation of signaling pathways and response to\ntherapeutic agents targeting the PKs. Here, we developed a kinase module of\ndeepCMD, and predicted 37 potentially important PKs in SCC (Figure 5A,\nTableS5C).Then,weperformedknock-downexperimentswithsiRN Asinboth\nHeLa and SiHa cervical cancer cells (Table S6). SiRNA targeting 12PKs\ninduced a > 1/3-fold suppression of proliferation of HeLa and SiHa (Two-sided\nt-test, p < 0.05, Figure S4A, B). From the results, 70.2% of the kinases with\nexperimental validations could achieve >2-fold increased confi dence of\nLLM-reasoning.\nFrom the results, siRNAs targeting CDK18 and CDK9 were the most\neffective in decreasing proliferation, with CDK9 inhibitorsranking as the top\neffective anti-tumor agents in Siha cells (Figure 5B). The re sults were\nconsistent with previous studies showing CDK9 involving in cervicalcancer\n46-48, supporting the reliability of kinase module predictions. More detailed\nstudiesindicatedthatsiRNAorinhibitorsofCDK9wereeffecti vein vitroinboth\nHeLa and SiHa cells (Figure 5C-D, Figure S4C-F). CDK9 inhibitors induced a\nG1 phase arrest (Figure S4H). Moreover, using HeLa cell-based xenografts\nand 3 cervical cancer patient-derived xenograft (PDX) mouse models, we\nfound that treatment of mice using CDK9 inhibitor (AZD4573) significantly\nsuppressedtumorgrowthwithoutapparenttoxicityasindicatedb ybodyweight\n(Figure 5E, Figure S5A-C). IHC of tumor slices from these mice confirmed\nincreased DNA damage (H2AX) and decreased cell proliferation (Ki67) after\ntreatment(Figure S5D, E).\nOfnote,CDK18hasnotbeenreportedtobeinvolvedinSCCprogr ession.\nUnfortunately, selective CDK18 inhibitors are not available.Therefore, we\nknocked out CDK18 with CRISPR/Cas9 technology in HeLa cells. Compared\nto parental cells, CDK18 depletion markedly reduced the transcription and\nproteinlevelsofHPV18oncoproteins(E6andE7)inHeLacells( Figure5F,G).\nThe E6 oncoprotein has been shown to degrade the tumor suppressor p53\nand the E7 oncoprotein can form complexes with the retinoblastoma pRB\ntumor suppressor 49. Consistent with these observations, TP53 protein\nexpression levels were increased and RB protein phosphorylation was\nmarkedly downregulated in all CDK18 knock-out HeLa cell clones (Figure 5F).\nCompared to the parental clone, proliferation of CDK18 knock-out clones was\nmodestly inhibited in vitro (Figure 5H) and tumor growth was completely\nsuppressed in xenograft mice (Figure 5I), supporting CDK18 as a therapeutic\ntarget in SCC. RNA-seq data further confirmed dysregulated HPV-related\nsignaling, RB andTP53pathway inCDK18knock-out cells (Figure S5F,G).\nNext, we stratified the patients using median kinase activity as the cutoff,\nand identified “Granularity_5_Hematoxylin” as an under-represented DIC in\ntumors with higher activity of CDK18 and CDK9 (Figure S5Jp = 0.0391).\nChatGPT interpreted this feature measures the heterogeneity in the intensity\nof hematoxylin-stained nuclei in WSI tiles, and a higher value ofthis feature\nindicates a higher heterogeneity of chromatin structures. For CD K18,\nChatGPT first interpreted its biological functions in transcriptional regulation\nduring mitotic cell cycle50, and then hypothesized that lower CDK18 activity\nmight lead to greater heterogeneity in chromatin organization with a higher\nvalue of this feature, because alterations in chromatin structure might disrupt\nDNA replication and repair51. However, ChatGPT interpreted the biological\nroles of CDK9 in regulating chromatin modifications involved i n active\ntranscription,suchasH3lysine4trimethylation(H3K4me3)andH3 K36me352.\nThus, ChatGPT hypothesized that lower CDK9 activity might lead t o\ndecreased levels of H3K4me3 and H3K36me3, resulting in a more closed\nchromatin structure, with a lower value of this feature. Taken t ogether,\nalthough the same DIC could be associated with different molecules,the\nphenotypic effects might be markedly different, due to the distinct functions of\nalteredmolecules.\nAgain, the contribution of our experiment validations on kinases was\nquantitatively evaluated. We queried ChatGPT on the relati ons between\npredicted kinases and SCC, with or without inputting our experimental results.\nFrom the results, we found that 70.2% of the 37 candidate kinases with\nexperimental validations could achieve >2-fold increased confi dence of\nLLM-reasoning, further supporting our contributions in filling the gaps of the\nexisting knowledge. The phenotypic efforts of 35 other predicted kinases were\nalso reasoned by ChatGPT (Table S1). Also, CDK18 contained higher kinase\nactivity in S-I subtype, which indicated that CDK18 could be a early stage\nmarkerofSCC (Figure 5K).\nReasoning and understanding of the single-cell heterogeneity of SCC\nFor SCSP profiling, an SCC tumor with 10 × 10 × 5 mm3 was first sliced into\n3608μmsections.AllsectionsweremarkedbyH &EstainingtoobtainW SIs.\nThen, we developed an SCSP module of deepCMD, which reached a high\nAUC score ranging from 0.988 to 0.997 on distinguishing malignant, immune\nand other cell images (Figure S6B). By further recognizing different tumor\nareas, we manually selected 113 heterogeneous regions with 100× 100 μm2\n(60-80 cells per point) from 3 randomly selected slices. Each regionwas\nnumbered and then cropped for SCSP profiling (Figure S6A). Seurat, a\nsingle-cell analysis tool53, was adopted to cluster the cells into 29 distinct cell\nstates,basedonimaging characteristicsofindividual cells (Figur e 6A).\nAs previously described54, we used an entropy-based method to identify\nsubtype-specificproteins,whichweredifferentiallyup-regul atedinasingle-cell\nsubtype compared to other subtypes. From the results, the 29 single-cell\nstates were designated. KRT85/86+, KRT82/31+, SPRR+, SCGB+,RABIF+,\nTRIP13+, TFAP4+, KRT75/76+, and ALPL+ subgroups were more likely to\nrepresentmalignantcells,whereas GLL1/ARHGAP17+,MBOAT1+, STAT5A+,\nABCD1/FGR+, TRMT2B+, TLE1+, PLD2+ and PSMD4+ subtypes were likely\nimmune cells (Figure 6B). We performed an enrichment analysis of GO\nbiological processes (p < 0.01, Figure S6H) for the top 50 state-specific\nproteins of each malignant cell subgroup and found that different processes\nwere preferentially regulated in different states of malignant cells. KRT85/86+,\nKRT82/31+, and SPRR+ cells were simultaneously enriched with\ncornification/keratinization, and TRIP13+ cells were enriched with cellular\nglucuronidation (Figure S6P). We selected CD4, SMA and CDK18 as\nrepresentative markers of immune, CAF and malignant cells to demonstrate a\nhigh overlap between predicted markers and IHC results at the single-cell\nresolution, supporting a high accuracy of single-cell deconvolution (Figure 6C,\np<<0.01). FromChatGPTinterpretations,we gotaP2Rof 13.1% formarkers\nknown tobeassociatedwith malignant,immuneorstromal cells (Tab leS1).\nThe 3D structure of the SCC tumor sample was re-constructed to\nvisualize the inter-tumor heterogeneity (Figure 6D). We found that CDK18\nwere highly expressed in 5 single-cell states, including2 malignant cell states,\nKRT82/31+ and ALPL+ cells, and 3 TME cell states, PVALB+, FMNL1+, and\nAKAP4+ cells. The CD8+ T cells with higher TLE1 expression were also\nlabeled,andwefoundthattheylocateoutsidetheregionofCDK 18+malignant\ncells, but are partially overlapped with CDK18+ niche cells (Figure 6D).\nFurthermore,we sought to deconvolutethesingle-cell compositionsof the114\nSCC patients. In the population level, the intra-tumor heterogeneity is highly\nconsistent with the inter-tumor heterogeneity at the single-cell level. For\nexample,malignantcellsweremarkedlyenrichedintheS-Iprot eomicsubtype,\nwhile immune cells were enriched in the S-III subtype, supporting a higher\nimmuneinfiltrationstatus intumorsof thissubtype(Figure S 6G).\nForeachsingle-cellstate,theimagesofcellnucleiweresegmented forall\nindividual cells recognized by Seurat, and superposed into an overlapped cell\nimage profile, or fusion image, for feature extraction (Figure 6E). The DICs\nassociated with all single-cell states were identified, such as\n“Mean_nuclei_AreaShape_NormalizedMoment_3_1”, “Mean_nuclei_Texture_\nAngularSecondMoment_Hematoxylin_3_01_256”, and\n“Mean_nuclei_Area-Shape_ConvexArea” (Figure 6F-H). ChatGPT interpreted\nthat this morphological feature denotes the irregularity orcomplexity of nuclei\nshape, and a higher value of this feature in malignant cell nuclei might reflect\nhigher chromatin condensation and alterations in gene expression, while\nimmune and TME cell nuclei might show less chromatin condensation with a\nlowervalueofthisfeature.Thisreasoningwasconsistentwithkn ownfunctions\nof CDK18 in regulation of transcription and chromatin organization 50, since\nthis feature was higher in CDK18+ single-cell states (Figure 6F). The second\nfeature was interpreted as a measure of the coarseness of the\nhematoxylin-stained nuclei, and malignant cells might have a higher value of\nthis feature with increased chromatin condensation in malignantcells, again\nconsistent with known functions of CDK18 (Figure 6G). The third feature\ndenotes the irregular shape of nuclei, and a higher value of malignant cells\nmight be associated with abnormal chromatin distribution. However, immune\nand TME cells with a higher value of this feature might indicateactivation or\nproliferation (Figure 6H). Taken together, the phenotypiccharacteristics of all\nthe29single-cell stateswere fully interpretedandreasoned(T ableS1).\nAn educated signal web of cell-cell communications within SCC\nIn tumors, malignant cells always participate in cell-cell communication\nwith immune and stromal cells55, and such a communication is essential for\ntumor metastasis and therapy resistance signaling56,57. With observation of\ndifferential immune infiltrating phenotypes in molecular subtypes and the\nsignificantly inhibitory effect of silencing CDK18 in HPV-integrated SCC cell\nlines, we integrated 21 single-cell state markers, 11 DEPs, 12 DPPs and 18\nChatGPT-proposedmolecules,including 8 experimentally validatedmolecules,\nand modeled an educated signal web of CDK18-centered cell-cell\ncommunications in SCC. From 53 functional associations and 43\nprotein-protein interactions (PPIs) interpreted by ChatGPT, 35.4% of them\nwere directed with unambiguous information flow, which helpe d us to\nunderstand the interplay of cell-cell crosstalk.Also, we found that38 of these\nassociationsandPPIswerenotcoveredbythe8publicPPIdatabase s(Figure\n7B). By integrating all descriptions of the signal web, we plotted a word cloud\nto present the hotspots, such as “MYC”, “TP53” and “RB1” within thenetwork\n(Figure 7D). Together with the interpretation and reasoningof ChatGPT, the\npotentially regulatoryroles ofCDK18was completelyunderstood inSCC.\nFrom the single-cell state profile, we observed that two and threecell\nstates with high CDK18 expression were malignant and niche cells,\nrespectively. The highest single-cell expression value of CDK18 wasfound in\ntheKRT82/31+cell state,andtheintracellularsignalingnetwo rk was analyzed\nin this cell state. According to previous reports, CDK18 is involved in DNA\nrepair of the ataxia telangiectasia and Rad3-related (ATR) pathway in gliomas\n58. Therefore, CDK18 might be associated with the integration of HPV in\ncancer cell genomes to help cancer cells maintaining their own chromosomal\nstability 59, and further generating reactive oxygen species (ROS) signals60.\nWith the help of ChatGPT-interpretation, we reasoned that cancer cells could\nreleasesuperoxidesignalstotheextracellularmatrixthrough NOX4,causinga\nform of programmed cell death (PCD), NETosis, to shield tumor cells from the\nkillerTcells by neutrophil extracellulartraps (NETs)61,62.\nAftersummarizing theexperimental resultsandthis inference, we queried\nChatGPT about the possible ways in which CDK18 protected malignant cells\nfrom immune cells. By interpretation and reasoning, ChatGPT suggested that\nCDK18wouldbemorelikelytoenhancethephosphorylationofret inoblastoma\n(RB), a critical tumor suppressor, to regulate the surface antigen programmed\ndeath-ligand 1 (PD-L1)63, which in turn allows tumor cells to evade CD8+ T\ncell immune regulation 64 (Figure 7C). With the new inference and\nexperimental results, the score of ChatGPT-reasoning further in creased,\nproving that the confidence in the causal relation was enhanced.\nSimultaneously, the potential mechanism of immune escape was also\ncaptured in KRT85+ malignant cells, showing a “don't eat me” signal of CD47\nandSIPRAinteractionwith macrophages 65.\nFurthermore, we observed the higher expression of a secreted\nglycoprotein, thrombospondin-1 (TSP1), in two types of niche cells, FMNL1+\nand PVALB+ cells, which also show higher CDK18 expression. ChatGPT also\ninterpreted that TSP1 could be secreted by endothelial cells and\ncancer-associated fibroblasts (CAFs) in the TME, and then bind to CD47 on\ninnate and adaptive immune cells, like innate-like mucosal associate d\ninvariantT(MAIT)cell,forimmunesuppression 66,67 (Figure7A).Therefore,we\nbelieved that there existed CDK18-mediated malignant, immune, and niche\ncellcrosstalk inSCC.\nDISCUSSION\nSCC is a prevalent gynecologic malignancy worldwide, and an in- depth\nunderstanding of its molecular characteristics is fundamental toprovide new\nsolutions for better diagnosis and treatment of the cancer. In recent years, a\nnumber of internationally collaborative projects such as TCGA,International\nCancer Genome Consortium (ICGC), and Clinical Proteomic TumorAnalysis\nConsortium (CPTAC) have profiled multi-omics across multiple cancer types,\nandhaveidentifiedmanynovelmolecularalterationsprovid ingnewinsightsfor\ntumor biology and precision medicine10,68-71. However, such an effort is yet to\nbe conducted in SCC, and how to appropriately interpret molecular alterations\nincanceris still a great challenge.\nOn the other hand, histopathological WSIs provide a direct, intuitive and\ncomprehensive means to provide rich phenotypic information on human\ndiseases at the single-cell level. To date, the SOTA AI technologyhas been\nimplemented for cancer cell segmentation and classification 72, cancer\ndiagnosis 73, and prediction of genetic alterations 74-76. How to use\nhistopathological data to facilitate the interpretation of can cer molecular\nalterationsis not known.\nRecently, the emergence of the new-generation AI technology, AIGC or\ngenerative AI (GAI), provides a potentially innovative means to accelerate the\nscientific discovery 14. The cutting-edge technology of AIGC/GAI is LLMs,\nexemplified by the release of ChatGPT by OpenAI15. Although numerous\ndebates have been raisedtheprosandconsof ChatGPT 14,77-80, its superiority\nhas been found with extraordinary abilities in text searching, summarizing,\ninterpreting, andreasoning, comparedto humanscientists.\nWith the help of ChatGPT interpretation and reasoning, we adopted the\nprompt engineering technology, and developed an iKLP strategyto precisely\nquery ChatGPT, by inputting prior knowledge and/or experimental evidence\nbefore asking questions. Most importantly, the CoTs of human scientists were\ndeliveredto ChatGPT forperceptionalignment.TheChatGPT- generated texts\nwere not directly used, but taken as a resource for further human\ninterpretations. In this way, ChatGPT completely interpreted knowns of 908\nmolecular alterations in cancer, with a P2R rate of 17.8%-20.3%for different\nomic layers. Obviously, biocuration of each molecule manually from the\nliterature is time-consuming and labor-intensive, and such tedi ous tasks\nshould outsourced to LLMs, together with following manual curation to ensure\nthe accuracy. Indeed, we found that non-existent references werefrequently\ngenerated by ChatGTP, together with other factual errors. Theanswers with\nerrors were excluded before further use. For the accountabilityof AI texts, we\nadded a timestamp for each prompt-generation pair to ensure the\nreproducibility of our study (Table S1). Together with a SOTA deep learning\npipeline,deepCMD,wefurtherenabledSCCtumorsubtypingan dpredictionof\nMOIs, including a potential biomarker protein HRG, and two therapeutic\nkinases,CDK18andCDK9.\nToexploitthephenotypiceffectsofmolecularalterations,we obtained645\nhigh-resolution WSIs from frozen sections, from tumors with or without paired\nNATs of 114 SCC patients (Figure S1A). The ability to performfrozen section\nanalysis within minutes as compared to days for FFPE analysis could\ncontribute to rapid implementation of patient management including precision\nmedicine. Using deepCMD, we analyzed the histopathological data to extract\ninformative features. Although frozen sectioning might introduce histological\nartefacts, our analysis of frozen sections captured multiple tumor pathological\nfeatures, which were interpreted and reasoned by ChatGPT to be causally\nrelatedto correspondingmolecularcharacteristics (Figure 1B-E).\nPrior to further experimental verifications, we queried the r elations\nbetween MOIs and SCC, and the confidence of ChatGPT was weak formost\nof newly identified candidates. However, when we included the evidence from\nexperiments, the confidence of ChatGPT-reasoning was dramatica lly\nincreased with >2-fold for 68.5% of tested MOIs, indicating the importance of\nhuman scientists’ efforts in uncovering the new biological findings. Finally, we\nre-constructed an educated signal web centered on CDK18 to understand the\ncell-cell communications in SCC. In the signal web, there were 71 ×70 / 2 =\n2485 potentially pairwise associations among the 71 molecules. Itwas not\npossibleforahumanscientistto check all associations,which were easily and\nrapidly accomplished by ChatGPT. In total, 96 known functional associations\nor PPIs were interpreted by ChatGPT, which pinpointed the dir ected\ninformation flow for 35.4% of the associations. With the help of ChatGPT, this\nsignal web was completely understood, and three potential cell-cell interaction\npatterns have been reasoned, including suppressing, blocking or deceiving of\nprotective immunecellsby malignantorTMEcells mediatedbyCD K18.\nTaken together, our study not only profiled molecular alterations with but\nalsocompletelydistinguishedknownsandunknowstofurtherunder standSCC.\nBesides interpretation of genomic mutations, molecular subtypes, biomarkers,\nactionablekinasesandsingle-cell states,LLMshelpedustoreasono utcausal\nrelationsforthesemolecularalterationsandcorrespondingph enotypiceffects,\nas well as an educated signal web for elucidating the cell-cell communication\nin SCC. Thus, with educated queries from human scientists, LLMs would\nefficiently provide highly useful information for interpreting and reasoning the\nbig biomedical data, toward a complete understanding of knowns a nd\nunknowns for any given scientific problems. We anticipate that such an\nimmersive-knowledge strategy might enable a fast, accurate, and low-cost\nmeans for feasible application in any scientific research. In addition, the\nemergence of cross-disciplinary reasoning that forms links betweendifferent\ndisciplines based on the learnt knowledge strongly implied the coming of a\nneweraof AGI.\nLimitations of Study\nThere are several limitations in our study. First, only 645 high-resolution WSIs\nwere obtained for extracting and analyzing histopathological imaging features\nwith a limited ethnic diversity of 114 Chinese SCC patients. We believe that\nthe results could be refined and further validated through theassessment of\nadditional WSIs particularly encompassing a diverse ethnic backgr ound.\nSecond, our experimental approaches were performed on a limited number of\npatient samples and SCC models. Analysis of additional patient samples and\npreclinical SCC models could provide the power to identify additional novel\nfindings and to provide further validation and generalization of the findings.\nThird, there were many types of clinical imaging data, such as computed\ntomography(CT)imaging,magneticresonanceimaging(MRI), a ndultrasound\nimaging that were not included in these studies. Including these imaging data\ntypes could provide an improved ability to identify relevant imaging\ncharacteristics of SCC. Fourth, due to budget limitations, we only conducted\nSCSP profiling of 113 samples. Additional SCSP data is expectedto provide\ndeeper insights into the single-cell heterogeneity of SCC and to aid in the\nidentification of additional therapeutic targets and potential biomarkers. Of\nnote, the minimum resolution of the SCSP profiling is currently tens of cells,\nand we hope to improve this technology to reach a single-cell resolution.\nFinally, more usages of LLMs should be tested to providing a bett er\nunderstandingofthe pathophysiology andtherapeuticmanage ment ofSCC.\nACKNOWLEDGMENTS\nWe thank Dr. Tiefen Su (T.S.), a senior gynecological pathologistat Tongji\nHospital, for her great help in labeling histopathological WSIs. We also thank\nDr. Wanshan Ning for his help in multi-modal data analysis. This work is\nsupported by grants from National Key R&D Program (2022YFC2704300,\n2021YFF0702000, and 2021ZD0201300), National Natural Scie nce\nFoundation of China (81630060, 81902653, 31930021, 319706 33 and\n81701567), Health and Family Planning Commission of Wuhan Municipality\n(WX18Q16),andHubeiInnovationGroupProject(2021CFA005) .Dr.YuXueis\na Vice Secretary General of Chinese Human Proteome Organization\n(CNHUPO).\nAUTHOR CONTRIBUTIONS\nD.M., Y.X., C.S. and G.C. initiated the project and oversee allaspects of the\nproject. F.L. and T.Q. collected the SCC tumor and NAT samples, and\nconductedthemulti-omicprofiling,withthehelpfromE.G.,D .P.,L.Z.,S.L.,J.F.,\nY.F., X.L, S.Y., and T.W. W.Z. and Y.G. developed deepCMD. W.Z. developed\ntheiKLPstrategywiththehelpofY.G.,C.H.,S.F.,D.L.,C.Z. ,andX.H. F.L.and\nT.Q. performed experimental validations, with the help fromB.Y., R.X., S.Z.,\nW.P.,K.S., C.Y., H.H., D.Z., B.X.,Y.P.,Y.S., B.W.,S.W.,P.W., W.C.,H.W., L.Y.,\nY.W., B.K., and G.B.M. D.M., Y.X., C.S., G.C. and W.Z. wrote the manuscript\nwith input from all the authors. All authors reviewed and appr oved the\nmanuscriptpriortopublication.\nDECLARATION OF INTERESTS\nTheauthorsdeclarenocompetinginterests.\nSTAR ★ METHODS\nRESOURCE AVAILABILITY\nLead contact\nFurtherinformationandrequestforresourcesandreagentsshou ldbedirected\ntoandwill befulfilledby theLead Contact,Ding Ma(dingma42 4@126.com).\nData and code availability\nThe raw WES-based exomic data and RNA-seq-based transcriptomic data\nhave been deposited to the National Genomics Data Center (NGDC ,\nhttps://ngdc.cncb.ac.cn/) 81 with the data set identifier HRA001899 (GSA for\nHuman). The raw MS/MS data of proteomic, phosphoproteomic, andSCSP\nprofiles have been deposited to the integrated proteome resources (iProX,\nhttps://www.iprox.org/) 82. The accession number of the MS/MS data reported\nin this paper is IPX0004056000. All data will be publicly released upon\npublication. The source codes of deepCMD have been uploaded to GitHub\n(https://github.com/BioCUCKOO/deepCMD).\nEXPERIMENTAL MODEL AND SUBJECT DETAILS\nEthics and Collection of Clinical Samples\nPaired tumors and NATs of 114 newly diagnosed, untreated SCC patients\nwere acquired from the biobank of cervical cancer from patients wh o\nunderwent primary surgery from May 2015 to December 2019. Patients with\nprior history of other malignancies within 12 months, any systemi c\nchemotherapy, endocrine or biological therapy as well as prior radiation\ntherapy to the abdomen or pelvis for any cancer type were excluded from the\nstudy. Tissue specimens were collected within 30 min after surgery and\nquickly frozen in liquid nitrogen. All of the patients were staged according to\nthe 2009 FIGO staging system. The histopathological features, including\nhistological type, pathologic grade, depth of cervix stromal in vasion,\nlymphnode metastasis, and lymphovascular space invasion (LVSI), were\nhistopathologically confirmed with FFPE slide post-surgery by professional\npathologist. This study has been approved by the Ethics Committee of Tongji\nHospital ofHuazhongUniversity of Science and Technology, andeachpatient\nhassigneda writteninformedconsent.\nCollection of Clinical Data\nIn addition to the basic information of the patients, the corresp onding\nexamination data of the patients in the hospital were also collected, including\nimaging examination, HPV detection, tumor biomarkers examin ation\n(AFP, squamous cell carcinoma antigens such as SCCAg, CA125, and CEA,\netc.), blood routine, urine routine, biochemistry, coagulation, blood sugar and\nother examinations. At the same time, the corresponding records of the\npatients' treatment during the hospital, such as radiotherapy a nd\nchemotherapy, were also recorded. Detailed clinicopathologic features were\nsummarizedinTableS2.\nCell culture\nHeLa and SiHa, two human cervical cancer cell lines, were purchased from\nAmerican Type Culture Collection (ATCC). All cell lines were fingerprinted by\nshort tandem repeats and confirmed to be free of mycoplasma contamination.\nCells were cultured in DMEM media plus 10% fetal bovine serum (FBS) and\ngrown ina 37°C incubatorwith 5%CO2.\nAnimals Models\n6-week-old female BALB/C nude mice were purchased from GemPharmatech\nCo., Ltd Company (Nanjing, China) and acclimated for 1 week before the\nexperiment under specific-pathogen-free conditions. All mice received human\ncare and the whole procedure was performed in accordance with the\nguidelines of the Committee on the Ethics of Animal Experiments of Tongji\nHospitalofHuazhongUniversity of ScienceandTechnology,Wuhan , China.\nMETHOD DETAILS\nData processing of histopathological WSIs\nLabeling and interpretation of WSIs\nToprepare a benchmark data set fortraining models of single-cell recognition,\nwefirstcroppedallWSIsintocontinuouslynon-overlappedtile swith128×128\npixels. To accurately distinguish the cell profiles, we randomly marked the\nborders of 18,789 cells by hand, in which the areas of inside single cells were\nlabeledin whiteandotherregions outsidecells were maskedinbl ack.\nFor single-cell classification, we randomly labeled 15,032 cancer cells,\n11,375 immune cells and 113,308 other cells by hand. Each cell wascropped\nandputintothecenterofasmallertilewith64×64pixels.Forar earecognition,\nwe randomly chose 26 WSIs to manually label the 4 typical areas, including\nparenchyma, stroma, keratinization and vessel, and the labeled areas were\n1.87×109, 1.88×10 9, 1.74×10 7, and 3.12×10 7 pixels, respectively. For\npreparation of different benchmark data sets, WSIs in TIFF format were\nmanually labeled and interpreted by two pathologists (T.S., a senior\ngynecological pathologist with >20 years’ experience; F.L., a gynecological\npathologistwith >10years’experiencein interpretingWSIs).\nTile-based QC\nTo evaluate whether tiles from tumors or NATs could accurately distinguished,\nwe cropped WSIs of tumors or NATs into continuously larger and\nnon-overlappedtileswith256×256pixels formorerapidtra ining.Alltilesfrom\ntumors or NATs were taken as input to train a CNN model, and the\nperformance of classification of tumor- or NAT-derived tiles was evaluated by\nthe10-foldcross-validationforQC.Tumortiles were usedforWSI -Subtyping.\nRepresentative tiles\nTo preserving the maximum amount of information, we selected thetile with\nthe most colored pixels in WSIs of each patient. In order to extract features, fit\nthesubtypesofpatients,thescoreofkeratinsfromarearecogniti onmodeland\nthe infiltration score from cell infiltration estimation were applied. We selected\ntileswith highestkeratinscore andwith highestcell infiltrationvalue.\nExtraction of quantitative features from images.\nA segmentation and feature extraction pipeline was built usingCellProfiler\nv4.2.1. The pipelinefirst unmixed H&E stains using the ‘UnmixColors’ module,\nthustheHematoxylinstainlayerwasextractedforfurtheranal ysis.Afterallthe\ncellnucleiintheimagesweresegmentedwith‘IdentifyPrimary Objects’module,\n644 element features were designed with modules including ‘Me asure\nGranularity’, ‘Measure Image Area Occupied’, ‘Measure Image Intensity’,\n‘Measure Object Intensity’, ‘Measure Object Intensity Distribution’, ‘Measure\nObject Size Shape’ and ‘Measure Texture’. Features of each cell w ere\nextracted and aggregated across the tile by mean, median, s.d. and deciles\n(10-quantiles) of the values. The quantitative features covered the size,\nshapes, pixel intensity distributions, textures of the objects, aswell as the\nrelation between neighbouring objects. The same image-processing pipeline\nwasutilized onrepresentative tilesto interpretmolecularsign atures.\nThe iKLP strategy\nFor prompt engineering, there were three modules in iKLP. Each of these\nmodules contained three steps to query the valuable informati on from\nChatGPT. The three modules were used in molecular interpretat ion,\ncross-disciplinary reasoning and new insights finding, respectivel y. The\ndetailedmodelsandsteps were shown below:\ni) Theinterpretationmodule.\nThe first step queried the basic informationfor analtered molecule. Based\non the answer of the first question, the second step appended the contextual\ninformation, such as cancer or cervical cancer. The third step queried a\nwell-established or potential pathway the altered molecule involved in to\nregulatecancerorcervical cancer.\nPrompt 1 (by human researchers):\n“Can you tell me the function of the protein \"MUC16\" (Mucin-16) of\nhuman?\"\nResponse 1 (by ChatGPT):\n“MUC16, also known as CA-125, is a protein that is primarily expressed in\nthe epithelial cells of the female reproductive system, including the ovaries,\nfallopian tubes, and endometrium. Its primary function is to act as a protective\nbarrier, preventing pathogens and other potentially harmful substances from\nentering the reproductive tract. MUC16 has also been implicated in cell\nadhesion, signaling, and regulation of the immune response. Additionally,\nelevated levels of MUC16 in the blood are often used as a biomarker for\novariancancer.”\nPrompt 2 (by human researchers):\n“Can you tell methefunction of theprotein \"MUC16\" (Mucin-16) of human?\nDoestheprotein\"MUC16\"involved in cervical cancer?”\nResponse 2 (by ChatGPT):\n“MUC16 is a type of mucin protein that is also known as CA-125. Its\nprimary function is to act as a protective barrier on the surface ofepithelial\ncells in various tissues, including the respiratory, gastrointesti nal, and\nreproductivesystems.MUC16isalsoknowntoplayaroleincelladhesi on,cell\nsignaling, and immune system regulation. In terms of cervical cancer, MUC16\nhasbeenshown tobeoverexpressedin cervical cancer cells andis thought to\ncontribute to the oncogenic potential of these cells. Elevated levels of MUC16\nhave also been associated with poorer prognosis and increased recurrence\nrates in cervical cancer patients. However, more research is neededto fully\nunderstand the exact role that MUC16 plays in cervical cancer development\nandprogression.”\nPrompt 3 (by human researchers):\n“Can you tell methefunction of theprotein \"MUC16\" (Mucin-16) of human?\nDoes the protein \"MUC16\" involved in cervical cancer? If the protein is\nconsideredtobeinvolved incervical cancer,tell methepossiblepath ways the\nprotein involved in regulating cervical cancer. If the protein isnot well known\nfor cervical cancer, tell me the potential pathway the protein could influence\ncervical cancer.”\nResponse 3 (by ChatGPT):\n“MUC16 is a transmembrane protein also known as CA125, which is\nprimarily expressed in epithelial tissues, such as ovarian, uterine, and cervical\nepithelia. The function of MUC16 is to mediate cell adhesion andact as a\nprotective barrier for the epithelial surface. It is also involved in signaling\npathways suchasMAPK andPI3K/Akt.\nMUC16 is known to be overexpressed in cervical tumors, and its elevated\nlevels have been proposed as a biomarker for cervical cancer. The protein is\ninvolved in several pathways that regulate cervical cancer progressi on,\nincluding the promotion of cell proliferation, invasion, and metastasis, as well\nasresistancetochemotherapyandradiation.Specifically,MUC16 canactivate\nthe Wnt/β-catenin signaling pathway, which promotes tumor gro wth and\nmetastasisincervicalcancer.MUC16canalsoactivatetheSrcfamilyki nases,\nwhich are involved in several cellular functions including cell cycleregulation,\nadhesion,andmigration.\nIn summary, MUC16 is involved in regulating cervical cancer progression\nvia multiple signaling pathways, including Wnt/β-catenin and Sr c kinase\nsignaling.”\nii) Thecross-disciplinaryreasoningmodule.\nThefirststepqueriedthedefinitionforanimagecharacteristic. Thesecond\nstep was based on the first question and querying the meaning of a higher or\nlower image feature value in HE pathological images. In the third step, human\nresearchers need to add comprehensive knowledge background for the\nmolecules of interests. Before the last query, the background knowledge was\nadded, including the summary of molecule, MUC16 for instance, taken from\nthe NCBI Gene database (https://www.ncbi.nlm.nih.gov/gene/94025), and the\nmajor findings from a representative paper from PubMed. The rationale of\nchoosing the representative paper was set as a cancer-related research from\nPubMed or the functional research listed in UniProt function summa ry\n(https://www.uniprot.org/uniprotkb/P50750/entry, CDK9 as an example). With\nthe appended information, we queried potential causal relation underlying the\nmolecularalterationandimagefeatures.\niii) Thenew insightsfindingmodule.\nThe first step queried the involvement of molecule in cervical cancer.\nBefore thesecond step, we summarized ourexperiment results,including IHC\nscores,CCK8experimentresults,mousemodelresultsorWesternblot results\nforeachverifiedmolecule.Asummary wouldbelike below:\n“There is additional information about \"PLK2\" (Serine/threonine-protein\nkinasePLK2)foryou.An RNAinterferenceassaywas conductedtarget ingthe\ngene “PLK2” in cervical cancer cell line HeLa. Results demonstratedthat cell\nviability was significantly inhibited in the experimental group compared with\ncontrol group(p-value< 0.05).”\nBy offering the experiment summary, we queried ChatGPT for th e\ninterpretation about our experiment of the molecule involvement in cervical\ncancer.Asforquestionsinsignal web,thesteptwoconsistsofthedef initionof\nPPIandquerying the associationorPPIbetweenmoleculepairs.\nIn the third step, we merged the first and the second questions together\nandasked ChatGPTto give a reasoningscore forthemoleculeinvolvementin\ncervical cancer. The score ranged from 0 to 10 and 10 means high\ninvolvementofmoleculein cervical cancer.\nQuestions from interpretation and reasoning were answered by ChatGPT\nAPI modal “gpt-3.5-turbo-0301”, or the ChatGPT webserver (Feb13 release\nandMar14release).\nAccuracy of positive response\nWe utilized Hallmark gene list from COSMIC database to check the accuracy\nof ChatGPT in responding of molecules involvement in cancer83. After the\noverlapping, we retained 81 hallmarks frompositively responded DEPs, DPPs\nand DEGs, while 49 hallmarks were negatively responded. By manually\ncheckingtheliteratures,theanswers fromChatGPTwouldbediscard edonlyif\nno literature could support its interpretation. The accuracy of C hatGPT\ninterpretationwas calculatedforDEP,DPPandDEG,respectively .\nMulti-omic profiling Workflow\nThe multi-omic analysis of the samples was performed according to the\nfollowing procedures. For QC, the following criteria were used for sample\nselection, 1) tumor cellularity analysis, three frozen sections (top, middle, and\nbottom)ofeachtissueblockwereresectedandsubjectedtoH&Estainin g.All\nH&E-stainedslideswerescannedandsubmittedfordeepCMDanalysis. Only\ntumors with at least the average of 60% tumor cell nuclei and less than 10%\nnecrosiswerereserved.Thehistologicalassessmentofalltumorsampl eswas\naccomplished by two experienced pathologists separately; 2) no tumor cells\nwereobservedintheNATs;3)qualifiedproteinextractionfrom bothtumorand\nNATs as revealed from the SDS-PAGE image without obvious pro tein\ndegradation and aberrant pattern. Finally, 114 high-quality paired samples\nwere selected for the multi-omic analysis. All tumors and NATs were then\npulverized and then divided into three parts. For each case, 300 mgtissue\nsamplewas usedforDNAandRNAextractionforWESandRNA-seq; 300 mg\ntissuesamplewas lysedwith SDSlysis buffer(4% SDS,100mMTris-HCl , 0.1\nM DTT, and pH 7.6) and kept in -80 °C for the following proteomic,\nphosphoproteomicanalyses.\nWES data analysis\nLibrary construction was performed with 1µg DNA per sample using Agilent\nSureSelect Human All Exon V6 kit (Agilent Technologies, CA, USA) following\nthe manufacturer’s recommendations. Briefly, DNA was fragmen ted to\n180-280bpbyhydrodynamicshearingsystem(Covaris,Massachusetts,U SA)\nand processed with end repair/A- tailing, adaptor ligation, an d library\nenrichment PCR using Kapa HyperPrep reagents. The resulting libraries were\nhybridized with liquid phase with biotin labeled probe, then processed using\nmagnetic beads with streptomycin to capture the exons of genes. Captured\nlibraries were enriched in a PCR reaction to add index tags to prepare for\nsequencing. Products were purified using AMPure XP system (Beckman\nCoulter, Beverly, USA) and quantified using the Agilent highsensitivity DNA\nassay on the Agilent Bioanalyzer 2100 system. The clustering of the\nindex-coded samples was performed according to the manufacturer ’s\ninstructions. After cluster generation, the DNA libraries were sequenced on\nIlluminaNovaSeqplatformand150bppaired-endreadswere g enerated.\nSomatic mutation calling\nThe clean reads of WES were obtained after the exclusion of low-quality\npaired reads, and mapped to the UCSC hg38 reference sequence84. The\nmaximalexactmatches(mem)programoftheBurrows-WheelerAli gner(BWA,\nversion 0.7.17, http://bio-bwa.sourceforge.net/\n)85 was usedforread alignment\nand addition of read groups. After the convert format from sam files with\nSamtools (version 1.10, http://www.htslib.org/) 86, the bam files were re-sorted\nand marked duplicates with Picard (version 2.21.4,\nhttp://broadinstitute.github.io/picard/\n). Two tools in Genome Analysis Toolkit\n(GATK version 4.2.0.0, https://gatk.broadinstitute.org/hc/e n-us) 87,\nBaseRecalibrator and ApplyBQSR, were used to recalibrate the basequality\nscores. The variants were called from tumors and paired NATs withMuTect2\nprogram of GATK. The gene- and filter- based annotation of Funcotator\nprogram of GATK were performed for variant annotation. Mutations in RNA\ngenes, the coding exons of transcripts with a complete open reading frame,\nand at the canonical splice donor or splice acceptor were retained. Intronic\nvariants, intergenic variants, and variants in the 3'UTR, 5'UTR, 3' flanking\nregion,and5'flankingregionwereremoved.Forobtainingth ereliablesomatic\nvariants, the following minimum supporting requirements were set: Minimum\ntumor supporting reads ≥ 2, minimum tumor VAF of 10%, minimum normal\nreferencesupportingreads≥8,andmaximumnormalvariantsupp ortingreads\n≤1.\nAnalysis of FMGs reported from previous cohorts\nFor comparison, FMGs previously identified from 5 cohorts were curated\n(Figure 2B). In 2013, Ojesinaet al. profiled 115 cervical carcinoma samples\nwithpairedNATs, from100patientsofNorwayand15patientso fMexico. The\n12 identified FMGs and corresponding mutation frequency values were taken\nfrom its Table 1 31. Using WES technology, TCGA research network\nsequenced 192 tumor-blood normal pairs, and 14 FMGs and corresponding\nmutation frequency values were taken from its Figure 1 10. Huang et al.\nperformed WES analysis of 102 tumor-NAT pairs from China, and 17 FMGs\nand corresponding mutation frequency values were taken from itsFigure 132.\nScholl et al. sequenced 182 samples from European, and 29 FMGs and\ncorresponding mutation frequency values were taken from its Figure 1 33.\nZammataro et al. sequenced 56 different tumor-normal pairs and 13\nunmatched samples from United States, and 14 FMGs and corresponding\nmutation frequency values were taken from its Figure 134. All collected FMGs\nweremerged andmappedtoourWESresults,afterredundancyclear ance.\nAPOBEC mutagenesis analysis\nAspreviouslydescribed 10,30,thenumberoftwo typesofmutationsoccurredin\na tCw motif, including tCw→tTw and tCw→tGw (w= A or T) mutations, was\ncounted asm for each tumor sample, in which the number of two types of\nmutations occurred in ±20 nucleotides around the middle cytosine was\ncounted asM. The numbers of all mutations occurred at the middle cytosine\nand flanking regions were denoted as n and N, respectively. Then, the\nenrichment ratio of theAPOBEC mutagenesis signature (APOBEC_enrich) was\ncalculatedasbelow:\nAPOBEC_enrich =\n\n\n\n\nFor tumor samples with APOBEC_enrich > 1, the statistical significance was\ndeterminedbyFisher’s exact test(p< 0.05).\nRNA-seq data analysis\nSample processing for DNA and RNA extraction\nDNAand RNA were extracted from tumor and NATs using QIAGEN’s AllPrep\nDNA/RNA Mini Kit. DNA concentrations were measured with QubitⓇ DNA\nAssay Kit in QubitⓇ2.0 Fluorimeter.Any sample that produced sufficient DNA\nyield and passed QC was subjected to sequencing. RNA concentration was\nquantified using the Qubit and quality was assessed using Agilent 2100. A\nsample that passed RNAQC and had a minimum RNAintegrity number (RIN)\nscoreof7 was sentforsequencing.\nRNA-seq\nLibrary construction was performed using 2 µg RNAper sample using VAHTS\nmRNA-seq v2 Library Prep Kit for Illumina following manufactu rer’s\nrecommendations. Briefly, mRNA was purified from total RNA using poly-T\noligo-attached magnetic beads. Fragmentation was carried out using\nfragmentation buffer. First strand cDNA was synthesized, and second strand\ncDNA synthesis was subsequently performed. Remaining overhangswere\nconverted into blunt ends. After adenylation of 3’ ends of DNA fragments,\nadaptorswithhairpinloopstructurewereligated.ThenPCRwa sperformed.At\nlast, Qubit HS quantification, Agilent 2100 Bioanalyzer/Fragment Analyzer\n5300QC,thefinallibrarysizewasabout350bp.Thelibrariesw eresequenced\non an Illumina NovaSeq platform to generate 150 bp paired-end reads,\naccordingtothemanufacturer’s instructions.\nVirus capture sequencing\nLibraries were prepared as described in our previous work and proceeded to\n151cyclesofpaired-endindexsequencingintheIlluminaNovaSe qsequencer\naccordingtomanufacturer's instructions.\nQuantification of mRNA expression\nFirst, the gene annotation format (GTF) of the GRCh38 assembly were\ndownloaded as the reference from GENCODE (Release 32,\nhttps://www.gencodegenes.org/\n) 88. The quantification of mRNA expressions\nwas calculated with RNA-Seq by Expectation Maximization (RSEM version\n1.3.1, http://deweylab.github.io/RSEM/) 89, based on the sequence aligned\nwith Spliced Transcripts Alignment to a Reference (STAR, version2.7.3a,\nhttps://github.com/alexdobin/STAR)90.\nQC and detection of DEGs\nThe log2-transformed upper-quartile normalized RSEM counts were usedfor\nthe following analysis. Based on the 10,217 mRNAs quantified inall samples,\nPCA was used for evaluation of the batch effect using Scikit-learn 0.22.1\n(https://scikit-learn.org/stable/). Then, we identified 2,424 potential DEGs that\nweresignificantlyalteredintumorsagainstNATs.TheFC value ofmedianwas\ncalculated, and mRNAs with |log2(FC)| > 1 were reserved. The statistical\nsignificance was calculated for each mRNA, using the two-sided Wilcoxon\nsigned-rank test, and adjusted p values were calculated using the\nBenjamini-Hochberg (BH) correction (adjusted p < 0.01). The stat istical\nanalyseswere conductedusingthewilcoxon functionin scipy.stats.\nOmic analysis of bulk proteomics and phosphoproteomics\nProtein extraction\nEach sample was grinded with liquid nitrogen into cell powder and then\ntransferred to a 5-mLcentrifuge tube.After that, four volumes of lysis buffer (8\nMurea(Sigma),1%proteaseinhibitorcocktail(Calbiochem),1%p hosphatase\ninhibitor for phosphorylation (Merck Millipore)) was added to the cell powder,\nfollowed by sonication three times on ice using a high intensity ultrasonic\nprocessor (Scientz). The remaining debris was removed by centrifugation at\n12,000 g at 4 °C for 10 min. Finally, the supernatant was collectedand the\nproteinconcentrationwasdeterminedwithBCAkit(Beyotime)a ccordingtothe\nmanufacturer’s instructions.\nTrypsin digestion\nFor following digestion, the protein solution was slowly addedto the final\nconcentration of 20% (m/v) trichloroacetic acid (TCA, Sigma) to precipitate\nprotein,thenvortexedtomixandincubatedfor2hat4°C.Thepre cipitatewas\ncollectedby centrifugationat4500 gfor5min at4°C.Theprecipi tatedprotein\nwas washed with pre-cooled acetone for 3 times and dried for 1 min. The\nprotein sample was then redissolved in 200 mM TEAB (Sigma) and\nultrasonically dispersed. Trypsin was added at 1:50 trypsin-to-protein mass\nratio for the first digestion overnight. The sample was reduced with 5 mM\ndithiothreitol (Sigma) for 60 min at 37 °C and alkylated with 11 mM\niodoacetamide (IAM, Sigma) for 45 min at room temperature in darkness.\nFinally,thepeptides were desaltedbyStrataXSPEcolumn(Phe onomenex).\nTMT 11-plex labeling\nAfter trypsin digestion, peptides were firstly dissolved in 0.5 M TEAB. Each\nchannel of peptide was labeled with their respective 11-plex TMT reagent\n(based on manufacturer’s protocol, Thermo Scientific), and incubated for 2\nhours at room temperature. Five microliters of each sample were pooled,\ndesalted and analyzed by MS to check labeling efficiency. After labeling\nefficiency check, samples were quenched by adding 5% hydroxylamine. For\nthe quantitative comparison between all samples across experiment batches,\nthe HeLa cell line was used as an internal reference and labeled with the\nreagent126ineachbatch.Thepooledsampleswerethendesaltedw ithStrata\nXSPEcolumn(Phenomenex) anddried byvacuumcentrifugation.\nHPLC fractionation\nThe sample was fractionated into fractions by high pH reverse-phase HPLC\nusing Agilent 300 Extend C18 column (5 μm particles, 4.6 mm ID, 250mm\nlength). Briefly, peptides were separated with a gradient of 2% to 60%\nacetonitrile in 10 mM ammonium bicarbonate pH 10 over 80 min into 80\nfractions. Then, the peptides were combined into 12 fractions and dried by\nvacuumcentrifuging.\nToincreasetheidentificationeffectofproteomeandphosphoryla tionsites,\na total of 3.3 mg TMT labeled peptides were fractionated by hig h pH\nreverse-phase HPLC using Agilent 300 Extend C18 column (5 μm particles,\n4.6 mm ID, 250 mm length), with a flow rate of 1 ml/min. Column oven\ntemperature was set to 35 °C. Solvent A (2% CAN, adjusted to pH 9.0with\nammonia) solvent B (98% CAN, adjusted to pH 9.0 with ammonia) were used\nfor peptide separation. A 97-min gradient was set as follows, 95% Ain 5 min;\n95%-92%A in 5 min; 92%-68%A in 57 min; 68%-5%A in 2 min; 5%A for11\nmin; 5%-95%Ain 5 min; 95%Afor 12 min. The eluate was collected every 1\nmin into 58 fractions from 21 min to 78 min. The 58 fractions werecombined\ninto 12 fractions for proteomic research or combined into 8 fractions for\nphosphorylationenrichment.\nPhosphopeptide enrichment\nPeptide mixtures were first incubated with IMAC microspheres\nsuspension with vibration in loading buffer (50% acetonitrile/0.5% acetic acid).\nThe IMAC microspheres with enriched phosphopeptides were centrifugated\nand collected. To remove the non-specifically adsorbed peptides, the IMAC\nmicrospheres were washed with 50% acetonitrile/0.5% acetic acid and 30%\nacetonitrile/0.1% trifluoroacetic acid, sequentially. To elu te the enriched\nphosphopeptides, the elution buffer containing 10% NH4OH was added and\nthe enriched phosphopeptides were eluted with vibration. Thesupernatant\ncontaining phosphopeptides was collected and lyophilized for LC-MS/MS\nanalysis.\nBulk proteomics and phosphoproteomics analysis\nThe tryptic peptides were dissolved in solvent A (0.1% formic acid, 2%\nacetonitrile/ in water), directly loaded onto a home-made reversed-phase\nanalytical column (25-cm length, 75 μm i.d.). The proteomic gradient was\ncomprisedanincreaseofsolventB (0.1%formic acidin90%acetonitr ile)from\n8%to 10%in 2 min,10%to 25% in 38min, 25% to40%in 14min,climbingto\n80% in 3 min and holding at 80% for the last 3 min, at a constant flowrate of\n500 nL/min on an EASY-nLC 1200 UPLC system (ThermoFisher Scientific).\nThen, the phosphoproteomic gradient of solvent B was set as follows: 3% to\n20% in 62 min, 20% to 32% in 20 min, 32% to 80% in 4 min and 80% for the\nlast 4 min, at a constant flow rate of 450 nL/min on an EASY-nLC 1200 UPLC\nsystem(ThermoFisherScientific).\nFor bulk proteomics and phosphoproteomics, the intact peptides w ere\nsubjected into NSI ion source (electrospray voltage: 2.1 kV) to ionize followed\nbyMS/MSinQExactiveTMHF-X(ThermoFisherScientifi),andOrbi trapwitha\nresolution of 120,000 was used for detection and analysis. The peptides were\nselected for MS/MS with normalized collision energy (NCE) settin g as\nNCE28%, and the fragments of peptides were detected in the Orbitrap at a\nresolutionof45,000.Adata-dependentprocedurethataltern atedbetweenone\nMS scan followed by 15 MS/MS scans with 30.0 s dynamic exclusion.\nAutomatic gain control (AGC) was set at 5E4, with an intensity threshold of\n5.6E4andamaximuminjectiontimeof90ms,andthefixedfirstma sswasset\nas100m/z.\nData normalization\nThe tandem mass tag (TMT)-based intensity matrix of proteins orp-sites was\nextracted from the MaxQuant output files of all batches. For eachprotein or\np-site, the TMT ratio value was calculated by dividing the intensity in the\ninternal reference cell line of the same batch. The proteomic and\nphosphoproteomic data of each sample was further normalized using the\nmedian centering method (median = 1). After normalization, the normalized\nabundance values (NAVs) of proteins or p-sites followed a logarithmic normal\ndistribution(log2)centeredatzero.\nMissing value imputation\nTo ensure the data quality and maximally use the proteomic or\nphosphoproteomic data, proteins or p-sites quantified in > 50% samples were\nreserved. Using the normal distribution imputation, the missingvalues were\nimputedwithvaluesfollowinganormaldistributionaroundt hedetectionlimitof\nthemassspectrometer.Foreachsample,themeanandS.D.ofthedist ribution\nof the raw protein or p-site were calculated. Then a new distribution with a\ndownshift of 1.8 S.D. and a width of 0.3 S.D. was automatically modeled. The\ntotal data set was imputed before statistical analysis. The data imputation was\nconductedusingPerseus1.6.14.\nBatch effect and QC\nThe batch effect due to TMT multiplexes was assessed by performingPCA\nusing Scikit-learn 0.22.1 (https://scikit-learn.org/stable/). The leading PCs of\nthe global proteomic or phosphoproteomic data clearly separated the tumor\nfrom normal samples, and no obvious batch effect was observed among the\n23TMTbatches.\nDE Analysis\nUsing NAVs of 6,749 proteins or 17,760 p-sites quantified in > 50% samples,\nweidentified1,394DEPs,1,191DPPs,and4,598DRPsthatweresi gnificantly\naltered in tumors against NATs. The FC value of median was calculated, and\nproteins, phosphoproteins or p-sites with |log2(FC)| > 0.5 were reserved. The\nstatistical significance was calculated for reserved proteins and p-sites, using\nthe two-sided Wilcoxon signed-rank test and adjusted p values wer e\ncalculated using BH correction (adjusted p < 0.01). The statistical analyses\nwereconducted usingthewilcoxonfunction inscipy.stats.\nEnrichment analysis\nThe two-sided hypergeometric test was adopted for the GO- or KEGG-based\nenrichment analysis of the DEGs, DEPs, or DPPs, respectively. Here, we\ndefined:\nN = number of human genes/proteins/phosphoproteins annotated by at\nleastoneterm\nn = number of human genes/proteins/phosphoproteins annotated by term\nt\nM =numberoftheDEGs/DEPs/DPPsannotatedbyatleast oneterm\nm =numberoftheDEGs/DEPs/DPPsannotatedbyterm t\nThen, the enrichment ration (E-ratio) was calculated, and the pvalue was\ncomputedwiththehypergeometric distributionas below:\nE-ratio=\n\n\n\n\np= '=\n (\n')(−\n−')\n(\n)\n\u0000 ,(E-ratio >1)\nIn this study, only statistically over-represented GO terms and K EGG\npathways were considered (p < 0.01). GO annotation files (released on 03\nJanuary 2020) were downloaded from the Gene Ontology Consortium Web\nsite (http://www.geneontology.org/), and in total we obtained 19,288 human\ngenes annotated with at least one GO biological process term91. KEGG\nannotationfiles(releasedon4September2020)weredownloa dedfromtheftp\nserverof KEGG(ftp://ftp.bioinformatics.jp/)92.\nOmics preparation of SCSP\nSample processing\nOne tumor sample was obtained from surgeries and then washed with PBS.\nAfter excess PBS on the tumor tissue surface was removed, the tissue was\nsoaked in liquid nitrogen pre-cooled isopentane for 1 min and then was\ntransferred in O.C.T. Compound (YEASEN, China) and snap frozen. The\nO.C.T.-embedded tissue was sectioned into 360 slides at 8 μm on a\nCryoStarTM NX60 cryostat (Thermo Fisher Scientific) and 3 sections were\nrandomly selected and mounted onto PEN membrane-coated glass slides for\nmicro-dissection.All tissue sections were stained with H & E as following. The\nslides were incubated at 37 °C for 1 min and then incubated in pre-cooled\nmethanol at -20 °C for 30 min. After residual methanol volatilized, each slide\nwas processed with isopropanol, hematoxylin, bluing buffer and eosin for 1\nmin,7min,2minand40srespectively.Andtheresidualbufferuse dinthelast\nstep should be washed with water. H & E stained tissue sections were then\nincubated at 37 °C for 5 min and visualized on digital slide scanner\nSLIDEVIEWVS200(OLYMPUS)at20×magnification.\nLaser-capture microdissection for SCSP\nFirst, WSIs of H & E staining from the three randomly selected sections were\nlearned by SCSP module, and then 113 small regions were marked based on\ntheirhistopathologicheterogeneity.Thereafterthese113r egionswereusedfor\nlaser-capture micro-dissection and SCSP as following: Laser-captu re\nmicrodissection procedure was completed on Laser-Capture Microdissection\nSystem (LCM) PALM (Zeiss). The LCM system was turned on and kept on for\n15mintostabilizethelaserenergy.Andmicroscopeandlasersettin gswereas\nfollows: Zoom: 20×; cut energy: 39; focus: 62; catapulting energy: 64；Focus:\n70;cycle number: 1; cutspeed: 100.Thedried-H & E-stained slide was putted\nonto the slide adapter of the LCM microscope. The 113 regions of interest\ncaptured by SCSP module was marked with LCM marker pen and\nmicro-dissectedusingabovementionedsettingsandcollectedwithm icrotubes\n(Zeiss,415190-9201-000).Themicro-dissectedsampleswerestored at-80°C\nordigestedforproteomic.\nProtein extraction and trypsin digestion\nThe micro-dissected samples were resuspended with 2 μL lysis buffer and\nwere sonicated for 3 min using a contactless high intensity ultrasoni c\nprocessor (Scientz) and then were incubated at 95 °C for 5 min. Protein\ndigestion was performed overnight at 37 °C after adding 1 µLof 30 ng trypsin.\nFor peptides desalting, home-made Stagetips were used follow ing the\nproceduredescribedbefore 93.\nSCSP analysis\nThe tryptic peptides were dissolved in solvent A (0.1% formic acid, 2%\nacetonitrile/in water), directly loaded onto a home-made reversed phase\nAnalytical column. Peptides were separated with a gradient from7% to 16%\nsolvent B(0.1%formic acid inacetonitrile)for4min,16%to26% solvent Bfor\n8 min, 26% to 40% solvent B for 3 min, and climbing to 80% in 2 min then\nholdingat80%forthelast3min,allataconstantflowrateof100 nL/minonan\nEasy-nLC 1000UHPLC system(ThermoFisherScientific).\nThe peptides were subjected to capillary source followed by the timsTOF\nPro (Bruker Daltonics) mass spectrometry. The electrospray voltageapplied\nwas 1.75 kV. Precursors and fragments were analyzed at the TOF detector,\nwith a MS/MS scan range from 100 to 1700 m/z. The timsTOF Pro was\noperated in parallel accumulation serial fragmentation (PASE F) mode.\nPrecursors with charge states 0 to 5 were selected for fragmentation, and 3\nPASEF-MS/MS scans were acquired per cycle. The dynamic exclusion was\nsetto30s.\nStandard database search\nThe resulting MS/MS data were processed using MaxQuant search engine\n(v.1.6.15.0).The MS/MS spectra were searched against the human SwissProt\ndatabase (20422 entries) concatenated with reverse decoy databaseplus 475\nSwissProt HPV protein sequences. Trypsin/P was specified as cleavage\nenzyme allowing up to 2 missing cleavages.The mass tolerance for precursor\nions was set as 20 ppm in first search and 4.5 ppm in main search, and the\nmass tolerance for fragment ions was set as 0.02 Da. The fixed modification\nwas set as Carbamidomethyl on Cys, oxidation on Met, acetylation on protein\nN-term and deamidation (NQ) were the variable modifications, and the\nPhospho (STY) was set for searching phosphoproteomes only. FDRs of PSM\nand protein were set to < 1%, and the minimum score for modified peptides\nwas set to > 40. The TMT 11-plex was selected in the quantificationmethod,\nandallotherparameters ofMaxQuant were setas defaultvalue s.\nThe deepCMD pipeline\nThe subtyping module\nSingle-cell recognition\nFor 688 tiles containing 18,789 cells with masked borders, pixelsinside cells\nwere taken as positive data, while pixels outside cells were taken as negative\ndata. For model training, we implemented a deep learning framework of a\nmodified 32-layer U-Net, a superior framework for image segmentation 86.\nBesides an input layer and an output layer, there were 30 hidden layers in our\nU-Net framework, including 4 set of dual convolutional layers and one pooling\nlayers(2×2),followedby2convolutionallayers,and4setofon econcatenate\nlayeronedeconvolutionallayeranddualconvolutionallayer s. Inthe30hidden\nlayers, neurons were the basic computation units, and both internal feature\nrepresentation and computational outcome were connected and propagated\nby neurons inside each layer. The convolutional layers were usedfor feature\nextraction and presentation. In each set of dual convolutional layers, the first\nlayer adopted a rectified linear unit (ReLU) function and the second one\nadoptedthesigmoidas theactivation function.They weredefin edas below:\nWherex wastheweightedsumofa neuron.\nIn the pooling layers, feature selection and information filtering were\nperformed by the max pooling strategy. The last hidden layer is a\ndeconvolutionallayerforgeneratingpredictionoutcomes.Int heoutputlayerof\nU-Net model, softmax nodes (128 × 128) were set to separately calculate\nscoresshown asbelow:\n  = \n=1\n \u0000\nWhereyi wastheinputof i-thsoftmaxnodederivedfromthedenselayer,and k\nwas the number of softmax nodes. In the final U-Net model, aScore(yi) was a\n0~1 value to represent the probability of a pixel to be inside oroutside regions\nofcells.\nAfter single-cell recognition, each recognized cell was cropped from tiles\nand put into the center of an image with 64 × 64 pixels in size for further\nanalysis.\nSingle-cell classification\n  = ,  ≥ 0\n0,  < 0\n  = 1\n1 + −\nImagesof 15,032cancercells,11,375 immunecells and113,308oth ercells in\n64 × 64 pixels were taken as the benchmark data set. Then, we designed a\n15-layer CNN framework basedon thearchitecture of VGG-16, a classic deep\nlearning framework for image recognition94. In our CNN framework, there\nwereaninputlayer,4setsofdualconvolutionallayersandone poolinglayer(2\n× 2), a dense layer and an output layer. In the convolutional layers, the ReLU\nfunction was adopted to activate the outcome of a neuron. The lasthidden\nlayer is a fully connected (dense) layer for generating prediction outcomes. In\nthe output layer of CNN models, softmax was utilized as activation function,\nand three scores ranged from 0~1 were calculated to represent the probability\nofacell tobea cancer,immune orothercell,respectively.\nArea recognition\nForparenchyma, stroma, orkeratinization areas recognition, the26 WSIs with\nthese three types of manually labeled areas were cropped into continuously\nnon-overlapped tiles with 128 × 128 pixels. Tiles containing at least one pixel\nof the corresponding area were taken as positive data, whereas all other tiles\nweretakenasnegativedata.Ofnote,onetilecouldbelongtomu ltipletypesof\nareas.Torecognize parenchyma, stroma or keratinization areas, models were\ntrainedona16-layerCNNframework,whichcontainedaninputla yer,4setsof\ndualconvolutionallayersandonepoolinglayer(2×2),2dense layersandone\noutputlayer.\nAfter recognition of parenchyma, stroma, or keratinization areas, exact\nkeratinization areas were segmented through a threshold-basedalgorithm 95\nfrom predicted keratinization tiles. Here, we defined the degr ee of\nkeratinization, based on the average scores of all pixels in a segmented\nkeratinizationregionas below:\n = /\nWhereDk denotes the degree of keratinization.Sk is the sum of keratinization\nscores of all pixels inside keratinization regions predicted by the CNN model\nforarearecognition. Ka is thenumberofpixels inside thekeratinizationarea.\nTo recognize vessel areas, all connected architectures in white\nbackground were first obtained from the 26 WSIs. Each connected\narchitecturewas croppedandputinto thecenterofa largertile w ith 512×512\npixels. The tiles containing vessels were taken as positive data, while other\ntiles were taken as negative data. For a more rapid training, these tiles were\nre-scaledinto128×128pixels, andthe16-layerCNN frameworkw asusedfor\nmodeltraining.\nCell infiltration estimation\nThe immune-to-cancer (i->c) cell infiltrations was estimated. The extent of\ninfiltration would be higher, if one type of cells more frequently permeates to\nother areas not normal to them. Thus, we hypothesized that the infiltration\nextent would proximately follow the normal distribution in a small\n2-dimensional (2D) region. Then, the Parzen window based on the Gaussian\nkernel was used to conjugate the distributions in all small windows to estimate\ntheglobaldistributionas follows 96:\n , \n= 1\nℎ2\n=1\n\n1\n2\u0000  −  − \n2 +  −  2\n2ℎ2\nWhere h is the window width, and the size ofh affects the accuracy of the\nprobability density estimation. The maximum likelihood estima tion (MLE)\nmethodwas usedtodeterminetheoptimal h value asbelow:\n  1, 1 , 2, 2 , ⋯, ,  |ℎ\n=  1, 1 |ℎ ×  2, 2 |ℎ × ⋯ ×  ,  |ℎ\nFor differenth values (from 0 to 500, +1 per step), we estimated the joint\nprobability density distributions for each cell from the remaining ones, until all\ncells were used once. The likelihood value is the product ofn probability\ndensity values as the extent of each of the (i->c) cell infiltrations, and the\noptimal h that maximized the likelihood value was calculated. For the\nimmune-to-cancer infiltration, the optimalh was determined as 82. Finally, the\nx was fixed, and the probability density distribution of its corresponding y\nvalues was computed.\nThen, we calculated the probability density distributions of the (i->c) cell\ninfiltrationsas below:\ni→c I1, v1 , i2, v2 , ⋯, iv |ℎ\n=  i1, v1 |ℎ ×  i2, v2 |ℎ × ⋯ ×  i, v |ℎ /( × N)\nWherefi->c istheaverageextentofimmune-to-cancerinfiltration, xi denotesthe\nlocation of an immune cell,NI is the number of immune cells, andNC is the\nnumberofcancercells..\nConventional clustering strategy\nFirst, the log2-transformed FC values of all DEPs were used for clustering\nusing the ConsensusClusterPlus (version 1.54.0,\nhttp://bioconductor.org/packages/release/bioc/html/ConsensusClusterPlus.ht\nml) package of R97. The basic parameters were set as follows:k-means\nclustering with up to 6 clusters (maxK = 6), 1,000-time repetitions (reps =\n1,000), resampling 80% of samples (pItem = 0.8) and resampling 80% of\nproteins (pFeature = 0.8). The number of clustering was determined by the\naverage pairwise consensus matrix within consensus clusters, and the delta\nplotoftherelativechangeintheareaunderthecumulativedist ributionfunction\n(CDF)curve.Becausetheconsensusmatrixwith k =3or k =4deemedtobea\ncleanest separation among clusters, and the delta plot showed that there was\nlittle increase in area fork = 3 compared tok = 4. Thus, the SCC proteomic\ndatawere clusteredinto3subgroups.\nUsing the same parameters, the log2-transformed FC values of all DPPs\nand DEGs were used for clustering at each omic layer using the\nConsensusClusterPlus.\nConsistent learning\nTooptimize theconsistencybetweenclinicalandmolecularcharacter istics,we\ndeveloped multi-modal clustering that included 3 steps, based on a n\nAutoEncoderframework 98.\n1) CF embedding. First, 16 CFs, including 2009 FIGO stage, histological\ntype, pathologic grade, tumor size, depth of cervix stromal invasion, lymph\nnode metastasis, LVSI, HPV-host fusion transcripts, HPV types, HPV\nintegration status, E6 expression, E7 expression unspliced E6, spliced E6,\nratio of unspliced to spliced E6, and HPV expression cluster (Table S2), were\nencoded for each patient. For a numeric CF,the corresponding value was first\nnormalized using the median centering method. For a taxonomicCF, the\ndifferentcategories N wereencodedasconsecutiveintegersstartingfrom1(1,\n2, 3, …,N). For a patienti, the corresponding CFs were then encoded into a\n1Dvector CFi asbelow:\n = (1 × , 2 × 2, 3 × 3, ⋯, 16 × 16)16\nWhere W1, W2, W3, …,W16 were weights of the 16 CFs, respectively, and the\ninitialvalue ofall weights wereequally set as1.\nThe CFi vectors of all patients were taken as the input ofAutoEncoder for\nembedding. AutoEncoder is an unsupervised deep learning framework that\ncompresses or embeds high-dimensional data into an informative feature\nvector to improve the efficiency of clustering and other analyses. A typical\nAutoEncoder consists of an encoder module and a decoder module. In cLCM,\ntheencodermodulecontained oneinput layer and fourdense layers, whereas\nthe decoder module was symmetric and contained four dense layersand one\noutput layer. The ReLU function was adopted to activate the outcome of\nneuronsin denselayers.\nIn multi-modal clustering, theCFi vector of patienti was automatically\nembeddedbytheencodermoduleintoa1Dfeaturevectorwith10v ariablesas\nbelow:\n\n' = (1\n' , 2\n' , 3\n' , ⋯,10\n' )10\nWhere 1\n' , 2\n' , 3\n' , ⋯,10\n' were values rangedfrom0~1.\nTo maximally reduce the information loss of feature embedding, the \n'\nvectors were uncompressed by the decoder module into vectors with 16\nvariables.Then,themeansquarederror(MSE)wascalculatedfor eachpairof\nthe originalCFi vector and uncompressed vector. The weights of neurons in\nthe hidden layers were iteratively optimized, and the learning process of\nAutoEncoder was terminated until the MSE value was not decreased any\nlonger. The final \n' vectors of all patients were used for further clinical\nsubtyping,usingtheconventionalclusteringstrategy.\n2)Omicdataembedding.Fortheproteomicdata,thelog 2-transformedFC\nvalues of1,394DEPswere takenas a1D vector Pi as below:\n = (, 2, 3, ⋯, 1394)1394\nNo weight values were assigned to DEPs. Using the encoder module, a\nPi vectorwas embeddedintoa1D featurevectorwith 10variables a sbelow:\n\n' = (1\n' , 2\n' , 3\n' , ⋯,10\n' )10\nAgain, to maximally reduce the information loss of embedding, the\ndecoder module was used to uncompress\n' vectors into vectors with 1394\nvariables, and the MSE values was calculated for each pair of original \nvector and uncompressed vector. The learning process was terminated until\ntheMSEvalueswasnotdecreasedanylonger.Then,thefinallyd etermined \n'\nvectors of all patients were taken for further proteomic subtyping, using the\nk-means clustering strategy from python package sklearn\n(https://scikit-learn.org/stable/index.html).\nAlso, similar methods were used for embedding 1,191 DPPs, and 2,424\nDEGs,respectively, togeneratethefeaturevectors withvariabl esforfollowing\nsubtypingateach omiclevel, usingtheconventional clusteringstr ategy.\n3) Randomized iteration. Using the chi-square test, the significance (p\nvalue) of the correlation between clinical subtypes and molecular subtypes\nwascalculated.Theinitialresultsofeitherclinicalormolecula rsubtypingmight\nnot be optimal, and their correlation was not significant (p > 0.05). Based on a\nhypothesis that optimal clinical and molecular subtypes should be as\nconsistent as possible with each other, a randomized iteration was\nimplemented. For vectors, one CF was randomly selected and its weight\nvalue was manipulated with +1 or -1 per time. For vectors, we randomly\ndiscarded 1~100 DEPs per time, and such a procedure was also adoptedfor\nother omic data types. Again, we used the chi-square test to test the\nsignificanceofthecorrelation,andthemanipulationwasadopt edifthepvalue\nwasdecreased.Therandomizediterationwasterminateduntil thepvaluewas\nnotdecreasedanylonger.\nIn multi-modal clustering, the AutoEncoderwas implemented inthe Keras\nversion2.2.4(http://github.com/fchollet/keras\n)basedontheTensorFlow1.13.1\n(https://github.com/tensorflow). Similarly, the AutoEncoder was also used to\ncalculate the correlatability between CFs, WSIs and multi-omics.First, the\nAutoEncoder was used to encode data of different dimensions intofeatures of\nthe same dimension, and then calculate the Spearman correlation of pairwise\nfeatures.\nThe biomarker module\nTo identify tumor- and subtype-specific protein biomarkers from DEPs, this\nmoduleconsisted of3steps.\n1) Random generation of combinations. From 1,394 DEPs alteredin\ntumorsagainstNATs,onlyDEPsupregulatedintumorsoraprot eomicsubtype\n(S-I, S-II or S-III) were separately reserved. Then, we randomly picked out 5\nDEPs to form a candidate biomarker combination. For each task, 100,000\ncandidatecombinationswere generatedasa pool.\n2) Calculation of the maximum accuracy. For each combination, the 5\nDEPsin eachtumororNATsamplewere encodedas a1D vectorasbelow :\n = (1 × , 2 × 2, 3 × 3, ⋯, 5 × 5)5\nWhereDEP1,DEP2,DEP3,…, DEP16 werevaluesoftheircorrespondingNAVs,\nandW1,W2,W3,…, W5 weretheircorrespondingweightvaluesandinitiallyset\nto1.\nFor each candidate combination, the ridge regression (L2 regularization)\npenalty in penalized logistic regression (PLR) was adopted foroptimizing the\nweights of the 5 proteins, and the 10-fold cross-validation was conducted to\ncalculate the AUC value. For tumor-specific combinations, all SCCtumors\nwere taken as positive data, and their paired NATs were taken as negative\ndata. For subtype-specific combinations, tumors in a subtype weretaken as\npositive data,whereasothertumors were takenasnegative data.\n3)Finalcombinationdetermination.Tomaximallyincreasingt hepredictive\nability of each combination, one or multiple DEPs were randomly discarded\nper time, and the weight values of reserved proteins were optimized by the\npenalized logistic regression (PLR). Then, the 10-fold cross-validation was\nre-performed to calculate theAUC value.The manipulation wasadopted if the\nAUC value was increased. Such an iterative procedure was terminated until\ntheAUC values was notincreasedany longer.\nForeachtask,top10combinationswerereservedandindividualpr oteinswere\nmerged to clear redundancy. The PLR algorithm was implementedin Python\n3.7withScikit-learn 0.22.1.\nThe kinase module\nTo identify potentially actionable PKs altered in SCC tumorsagainst NATs, we\ndevelopedathree-stepmoduleshown as below:\n1) Re-construction of site-specific kinase-substrate phosphorylatio n\nnetwork(ssKSPN).First, weobtainedthestandardgenenamesof5 24human\nPKs from a previously developed database iEKPD 2.0\n(http://iekpd.biocuckoo.org/), which contained 109,912 known and predicted\nPKs in 164 eukaryotes99. Then, the upstream regulatory PKs of 4,958 DRPs\naltered in tumors against NATs were predicted by iGPS\n(http://igps.biocuckoo.org/), in which sequence-based information and PPIs\nbetween PKs and substrates were integrated to accurately predictpotential\nsite-specific kinase-substrate relations (ssKSRs) for 408 human PKs100. The\ndefaultparametersofthe“Lowthreshold”and“Experiment/S TRINGPPI”were\nselected in iGPS. Based on predicted ssKSRs, an integrative ssKSPN was\nre-constructed,inwhich individualPKs orDRPs were network nodes.\n2) Merging samples. To enhance the p-site intentities, we summed up\nintensitiesfromeachtumorsamples,whichwasconductedtoNATsampl esas\nwell.Fora DRPin mergingstep,its finalintensity was calculatedas below:\n− = [1, 2, …, 111]\n− = [1, 2, …, 111]\nWhereSi is thep-siteintensity ofsample i in atumororNAT.\n3) Prioritization of final actionable PKs. To narrow down the in itial\ncandidates, we further calculated the statistical significance for individual PK.\nFirst, individual PK networks were extracted to contain a PK and its substrate\nDRPs. For each DRP, the sum of NAVs in tumors or NATs was counted,\nrespectively. Here, we defined the kinase network state (KNS) to measure a\nPK to be altered or unaltered. The KNS score of a PK i in sampleA was\ncalculatedasbelow:\n =\n=1\n\n()\u0000\nWhere () equals to the corresponding merged p-site intensity\n− or −.Thechi-squaredtestwasusedtotestthesignificance,\nwiththe2x 2 contingencytableshown asbelow:\nNATs Tumors Total\nPKi  = ()  = ()  =  + \nOthers  =  − ()\n = \n− ()\n =  + \nWhole  =  +   =  +   =  +  +  + \nForeachtest,p(< 0.05)was calculatedandthedegree was set as1.\nThe SCSP module\nSingle-cell clustering\nFrom 3 WSIs that were used to crop small regions for SCSP profiling, we\nrandomly selected 34,322 cells after single-cell recognition andclassification.\nIn the 15-layer CNN framework for single-cell classification, features in last\ndense layer were extracted for each cell. Using retrieved features of all the\n34,322 cells, single-cell clustering was conducted by R package Seurat4.0.2\n53.\nThe SCSP deconvolution\nOur basic hypothesis for deconvolution of single-cell types is that if different\ntypes of immune cells could be correctly recognized, other cell types including\nmalignant cells and stroma cells might be also correctly decoded. With the\nhelpofWSIsandbulkproteomicdataofSCCpatients,wedeconvo lutedwith3\nstepsasbelow:\n1) Deconvolution of the spatial proteomes of the 29 single-cell subtypes.\nUsing this module, single cells in the 113 regions were accuratelyrecognized,\nand classified into 29 pre-configured subtypes, including 9 typesof malignant\ncells, 8 types of immune cells and 12 types of stroma cells. In a small region,\nthe overall expression level of a protein could be proximately estimated as the\nsum of its expression levels in a distinct cell type multiplied by the number of\ncells for this type. For each small region, the numbers of the 29 single-cell\nsubtypes were counted and then the matrix of expression levels of3,541\nproteinsin the29subtypes wasfittedbyNMF fromtheSCSPdata as below:\n0 = 0 × 0\n0 =\n [1, 1] ⋯  [1, 3541]\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n [113, 1] ⋯  [113, 3541]\n113×3541\n0 =\n [1, 1] ⋯  [1, 29]\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n [113, 29] ⋯  [113, 29]\n113×29\n0 =\n  pro[1, 1] ⋯   pro[29, 3541]\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n  pro[29, 1] ⋯   pro[29, 3541]\n29×3541\nV0 was the SCSP expression matrix in each region. A row inV0 was the\nSCSPexpressionin one ofthe 113small regions.W0 is thenumbers of the 29\nsingle-cell subtypesin oneof the113small regions.\nIn the NMF model training,H’ was iteratively updated and theV’ was\ncalculatedasbelow:\n' = W0 × '\nTo evaluate the performance of NMF-based optimization, we usedthe\nEuclideandistance ED asameasurement asbelow:\n =\n0[1,1]2 ⋯  0[1, ]2\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n0[, 1]2 ⋯ 0[, ]2\ni×j\n+\n'[1,1]2 ⋯  '[1, ]2\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n'[, 1]2 ⋯  '[, ]2\ni×j\n− 20'\nWhere 0[, ]was theelement atrowi andcolumn j.The NMF model training\nwas terminated until theED was not decreasing any longer. TheH0 was the\nfinally determinedH’. Then we obtained matrixH0, the expression levels of\n3,541 proteins in one of the 29 single-cell subtypes. WhereSpatial pro[pi, ri]\ndenoted the expression level of protein pi in region ri. Cell number[ri, ci]\ndenoted the number of single-cell subtypeci in regionri, andSingle cell pro[ci,\npi]denoted theexpression level ofproteinpi insingle-cell subtypeci.\n2) Estimation of the proportions of the 29 single-cell subtypes in tumor or\nNAT samples of SCC patients. Using matrix H0, NMF determined the\nproportions of the 29 single-cell subtypes in each patient sample, using bulk\nproteomic dataasbelow:\n1 = 1 × 0\n1 =\n [1, 1] ⋯  [1, 3541]\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n [222, 1] ⋯  [222, 3541]\n222×3541\n1 =\n [1, 1] ⋯  [1, 29]\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n [222, 1] ⋯  [222, 29]\n222×29\nMatrix V1 is bulk expression of the same 3,541 proteins in 222 patient\nsamples, and matrixW1 is the cell numbers of the 29 single-cell subtypes in\nthese222samples.Theoptimal W1 was determined using thesample method\nforH0. WhereBulk pro[si, pi]denoted theexpression ofprotein pi in samplesi.\n3) Deconvolution of the remaining proteomes of the 29 single-ce ll\nsubtypes.Then, theprotein expressionlevels of6,694proteins notdetectedin\nSCSP profiling were accurately determined by NMF for each of the 29\nsingle-cell subtypesas below:\n2 = 1 × 1\n2 =\n [1, 1] ⋯  [1, 6694]\n⋮ ⋱ ⋮\n⋮ ⋱ ⋮\n [222, 1] ⋯  [1, 6694]\n222×6694\nH1 is theexpressionlevels of6,694proteins in the29single-cell subtypes.\nV2 is the bulk proteomic expression matrix of 222 patient samples.Again, the\noptimalH1 was determinedusingthesamplemethod for H0.\nWe mergedH0 and H1 to get the expression matrix of 10,235 proteins in\n29 single-cell subtypes. We pursued that the protein markers of know n\nimmune cells could be found in the single-cell level proteomic expression\nmarkers of immune clusters as more as possible. In this case, we curated a\nspecific geneset frompublications as gene signature ofimmune cell subtypes\n(Table S5) (Miao et al., 2020) and the enrichment ratios of known markers in\nthe corresponding immune cell subtypes were calculated and iterat ively\noptimized.The loss ofdeconvolution was controlled tofluctuate within 5% and\nthe result with the greatest enrichment ratio of known immune cellmarkers\nwaspreserved.\nIdentification of potential single-cell marker proteins\nAs previously described54, an entropy-based method was adopted to identify\npotentialsingle-cell heterogeneityproteinsin18single-cel l subtypes.Foreach\nprotein, its relativeNAV (rNAV) value in a single-cell subtypej was defined as\nbelow:\n =\n\n1\n \u0000\nWhere NAVj was the normalized expression value in the single-cell subtypej,\nandΣNAV was thesumofall NAV values inall single-cell subtypes.N was the\ntotal number of single-cell subtypes. Then, the Shannon entropyH of this\nproteinacross differentsingle-cell subtypescouldbecalculateda s below:\n =−\n1\n\n × 2()\u0000\nWhere the value ofH ranged from 0 to log2(N).Asmaller H score represented\na higher probability of a protein to be a real single-cell heterogeneous protein.\nBased on the distribution ofH scores, proteins with entropy < 2 were reserved\naspotential single-cell markerproteins.\nRe-construction of the 3D structure of a SCC tumor\nDuringslicingthetumors,slightvibrationoccurredtoresultinsli ghtlyrotatedor\ncrooked sections. For image registration, one of the WSIs of two adjacent\nsections was rotatedby onedegree perstep,maximally rangedfrom-30to 30\ndegrees. The optimal rotated angle was determined based on themaximally\noverlappedareasoftwoadjacentWSIs.Foreachsection,individu alcellswere\nrecognizedbythismoduleandclassifiedintothe29single-cellsub types.Then,\na 3D structure was re-constructed to illustrate the single-cell heterogeneity of\ntheSCCtumor.\nPerformance measurements\nTo evaluate the accuracy of deepCMD, true positive (TP), true negative (TN),\nfalse positive (FP) and false negative (FN) values were counted, respectively.\nThen, we calculated 6 commonly-used measurements, including sensitivity\n(Sn), specificity (Sp), accuracy (Ac), positive predictive value (PPV), negative\npredictivevalue (NPV), andMathew correlationcoefficient (MCC)asbelow:\n = \n + \n = \n + \n =  + \n +  +  + \n = \n + \n = \n + \n =  × −  × \n + ×  + ×  + ×  + \nFor each method, the 10-fold cross-validation was repeatedly performed 10\ntimes, and averageSn, Sp, Ac, PPV, NPV and MCC values were calculated.\nThe receiver operating characteristic (ROC) curve was illustrated based on\nfinalSn and1-Sp scores,andtheAUC value was computed.\nModel training and parameter optimization\nFormodeltraining,the10-foldcross-validationwas usedtoprev entoverfitting.\nWe randomly generated a training dataset and a testing dataset with a size\nratio of approximately 9:1. We further randomly split the training dataset into\nten parts, of which nine were used for model training. Then, we used the\nremaining part to calculate the average Ac value, and the process of\nparameter optimization was stopped when the Ac value was no longer\nincreased. The randomization and parameter optimization on the training\ndatasetwasperformedtentimes,andthemodelwiththehighest Ac valuewas\nretained.Using the determinedparameters, the final model was trained onthe\nfull training dataset. The testing dataset was not used for training, and was\nonly used to countTP, TN, FP and FN values and calculate the performance\nmeasurements.\nA lab computer with an Intel(R) CoreTM i7-10700K@ 3.80 GHz central\nprocessing unit (CPU), 64 GB of RAM and a NVIDIAGeForce GTX 2060 core\nwas used for model training. The Keras version 2.2.4\n(http://github.com/fchollet/keras\n), a highly useful neural networksAPI that was\nwritten in Python and developed based on the TensorFlow 1.13.1\n(https://github.com/tensorflow\n), was adoptedforparallelcomputing. U-Net and\nCNN models were trained by minimizing cross entropy loss between final\npredictions and ground truth labels. During training, the Adam optimizer in\nKeraswas adopted,anda decay factord was usedtocontrol thelearningrate\nateachepoch shownas below:\n =  × 1\n1 +  × \nWherelr was theinitial learningrate andlri was learningrateat i-th epoch.For\nall models, adjustable parameters such as the dropout ratio, initial learning\nrate, decay, and batch size were simultaneously optimized to improve the\nperformance(TableS1).\nSignal web construction\nWe extracted PPIs information of nodes in the knowledge net from 8 common\nPPI databases, including BioGRID101, IID 102, inBio MapTM 103, Mentha 104,\nHINT 105, iRefIndex 106 and PINA 107. In addition, we obtained transcription\nfactor regulatory information from database TRRUST108 and TcoF-DB 109.\nPhosphorylationregulatoryinformationfromPhosphositePlus 110toconstructa\nbasic network along with information from ChatGPT. The signalweb was\nconstructed and visualized with Cytoscape 3.9.0 software. Venn plotwas plot\nbyJvenn (http://jvenn.toulouse.inra.fr/app/example.html).\nFunctional experiments of protein regulators\nCell counting after interfered with RNA interference (RNAi) or inhibitors\nThe siRNAs were synthesized by Millipore Sigma Company (Burlington, MA,\nUSA, Table S6). Scramble siRNA was used as a negative control. Cells were\ntransfected with siRNAs using Lipofectamine TM 3000 (ThermoFisher\nL3000015, Waltham, MA, USA) at 50 nM final concentration. CCK-8 assays\n(Dojindo Laboratories, Japan) were used to detected cell counts 72h after\ntransfection. Three independent replicates were performed fo r each\nexperiment.\nTo test the anti-tumor effects of PK inhibitors, 3000 HeLa or SiHa cells\nwere plated in 96-well plates, and then treated with inhibitors as indicated for\n72 h, thereafter CCK-8 assays (Dojindo Laboratories, Japan) were used to\ndetected cell counts. At least three independent replicates wereperformed for\neachexperiment.\nCell proliferation assay\nFor observing the effect of RNAi on cell proliferation,1500 HeLaor SiHa cells\n24 hours after transfection with indicated siRNA were plated in 96-well plates\nfor, and then cell proliferation were detected by CCK-8 solution (Dojindo\nLaboratories,Japan)atdifferenttimepointsas indicated.\nColony formation assay\nHeLa or SiHa cells were seeded into 12-well plates (1500 per well) and\nallowed to adhere about 12 hours. Cells were cultured for another 9 days with\ndifferent drugs with concentrations as indicated. Cells were then fixed with 4%\nparaformaldehyde, stained with 0.5% crystal violet, and photographed using a\ndigital scannerafterdrying.\nCDK18 knockout with CRSPR Cas9\nThe lentiCRISPRv2 sgRNA vector (Addgene #52961) is gifted by Professor\nFeng Zhang. SgRNA sequences for CDK18 interference are designedwith\nGPP sgRNA designer, an online tool available at\nhttps://portals.broadinstitute.org/gpp/public/analysis-tools/sgrna-design\n. The\nsequences are indicated as follows: sg#1\nCACCGCACAGATCGGTCCCTCACCC; sg#2\nCACCGCAAACTGACGGAGAACCTTG. For lentivirus production, tw o\npackaging plasmids pCMV8.9and pCMV-VSVG were utilized accordingto the\nmanufacture’s protocols (Thermo Fisher Scientific). CDK18 knock out cells\nwere generated using lentivirus-mediated transduction and thensubmitted to\npuromycin selection for 48h. Monoclonal cell lines are harvested through\nsingle cell pickingandvalidatedby Sangersequencing\nWestern blot analysis\nCells were treated as indicated and total protein was extracted from the\ncollected cells with RIPA lysis buffer, and the protein concentration was\ndetermined with Coomassie blue. Every sample was added with 20%loading\nbuffer and boiled for 15 minutes, then 20ug of total protein was added to each\nwell by SDS–PAGE gels. After transferring with PVDF membrane,it was\nblockedwith 5% nonfat dry milk inTBSTfor 1h atroom temperature,and then\nincubated with primary antibody (antibody information wereprovided in key\nresources table) at 4 °C overnight. The secondary antibodies wereincubated\nfor 2h at room temperature. The signal of western blot was collected using\nenhancedchemiluminescence(Bio-Rad).\nqRT-PCR assay\nAccording to the steps of the instructions, the total RNAwas extracted using a\ntotal RNA isolation kit (Vazyme Cat. RC112-01). Next, total RNA(1 μg) was\nreverselytranscribedintocDNAwiththeHiscriptQ-RTSuperMix(V azymeCat.\nR223-01).The SYBR PCR MasterMixes kit (Vazyme Cat. Q711-02)wasused\nfor the thermocycling reaction in a CFX96 Real-Time system (BioRad). The\nmRNA levels analysis was used by ∆∆Ct method and normalized by gene\nβ-Actin.All Primerssequencesare listedinTableS6.\nCell Cycle assay by flow cytometry\nTo measure the cell cycle, cells were treated with different concentrations of\ninhibitors for 48 hours, then harvested for flow analysis. Aftercollecting cells,\nthe cells were fixed in 75% alcohol at 4 degrees overnight. Next, cells were\nwashed with PBS and stained with 20 mg/ml propidium iodide (PI)which\ncontained 100 mg/ ml RNase A. Finally, the samples were detected by flow\ncytometry (Beckman Coulter), and at least 10,000 cells were detected in each\nsample.FlowJo-V10software was usedtoanalyze data.\nHeLa Xenograft experiments\nFor HeLa Xenograft models, 5×106 cells in 100μl PBS were subcutaneously\ninoculatedattherightflankofeveryBALB/Cnudemouse(6-wee k-oldfemale).\nWhen xenograft tumors of mice reached approximately 100 mm3 in volume,\nmicewererandomlygrouped(6micepergroup)anddosingstarted. Thedrugs\n(AZD4573: Selleck CAS No. 2057509-72-3, BI6727: Selleck CAS N o.\n755038-65-4) were all dissolved in 2% DMSO+30% PEG300+5% Tween\n80+ddH2O. The mice were treated as follows: 1) Vehicle; 2) AZD4573 20\nmg/Kg, oral gavage, BID, 2h apart, 2 days on 5 days off; 3) BI6727 10 mg/Kg,\noral gavage, QD, 4 days on 3 days off. The tumor volume was calculated as\nfollows: V = (L×W2)/2 (L: length; W: width). All mice were sacrificed at the\nendpoint of drug administration and tumors were harvested for subsequent\nexperiments.\nIn addition, 5×106 parental HeLa cells and the CDK18 KO cell clones\n(sg#b2 or sg#e1) were transplanted into the right and left flanksat the same\nmicerespectively.Mice were monitoredandsacrificedas mentioned above.\nPDX experiments\nAll PDX mouse models of cervical squamous cell cancer were established\npreviously in our lab.All established PDX models have been approved by the\nEthics Committee of Tongji Hospital of HUST, and each patient has signed a\nwritteninformedconsent.\nForin vivoexperiments,freshtumortissueofPDXswereminced(0.1–0.2\ncm3), and then subcutaneously implanted on the right side of 6-week-old\nfemale BALB/C nude mice. When the volume of xenograft tumors reached\napproximately100mm3,micewere randomly grouped(5 or6mice p ergroup)\nandtreated asfollows:1) Vehicle; 2)AZD457320 mg/Kg, oral gavage, BID, 2h\napart,2dayson5daysoff;3)BI672710mg/Kg,oralgavage,QD, 4days on3\ndays off. The drugs (AZD4573: Selleck CAS No. 2057509-72-3, BI6727:\nSelleck CAS No. 755038-65-4) were all dissolved in 2% DMSO+30%\nPEG300+5% Tween 80+ddH2O. Mice were monitored and sacrificed as\nmentionedabove.\nIHC\nAll tumor tissues were fixed in 4% paraformaldehyde overnight and\nparaffin-embedded. IHC was performed on 4μm-thick sections. Embedded\nIHC sections were deparaffinized in xylene and hydrated firstly.All slides\nwere boiled in antigen retrieval solution (citrate buffer, 10mM, and pH 6.0) for\n15 minutes and blocked in 3% hydrogen peroxide for 15 min at 37°C.Slides\nwere rinsed in PBS 3 times and blocked with 5% goat serum albumin for 60\nminatroomtemperature.Next,allslideswereincubatedwithp rimaryantibody\n(antibody information were provide in the key resources table)overnight at\n4 °C. Incubating the biotinylated secondary antibody and horsera dish\nperoxidase according to the instructions (ZSGB-BIO, Rabbit SP kit, SP-9001;\nMouse SP kit, SP-9002). Subsequently, slides were incubated with DAB\n(ZSGB-BIO, DAB Chromogenic kit, ZLI-9018) and then stained wi th\nhematoxylin.Aftercoverslipping,slideswerescannedunderamicr oscopeand\nphotographed. Tumor cell staining were semi-quantified with five-category\ngrading system: 0, no staining; 1, 1-25% staining; 2, 26-50% staining; 3,\n51-75% staining; and 4, >75% staining, and staining intensity wa s\nsemi-quantified with five-category grading system: 0, no staining; 1, weak\nstaining; 2, moderate staining; 3, moderate-strong; and 4, strong staining.The\nfinal IHC score was obtained by the formula：Tumor cell staining × staining\nintensity for each protein. Every core was assessed individually and the mean\nof three readings was calculated for every case. The IHC score was\ndetermined separately by two independent experts simultaneously under the\nsame conditions. In rare cases, discordant scores were reevaluated and\nscoredonthebasis ofconsensus opinion.\nRNA-seq and GSEA analysis\nThe HeLa cells and HeLa CDK18 Knockout sg#b2 cells were collected and\nextracted the total RNA using an RNA extraction kit (Vazyme Cat. RC112-01).\nAfter determining of RNA concentration and integrity, total RNA was used to\ngenerate poly(A)+ RNA for construction of an RNA-seq library by Annoroad\nGene Technology Co., Ltd. RNA-seq was performed on the MGISEQ-2000\nplatform. All samples have 3 independent biological replicates. The pathway\nenrichment analysis was explored with GSEA analysis with the clusterProfiler\npackage.\nSurvival analysis\nFor HRG or PLK1, we stratified SCC patients into two groups as high and low\nprotein expression, based on the TMA results. To evaluate the prognostic\npowerofeachprotein,thetwo-sidedlog-ranktestisperformed fortheOSdata\n(p < 0.05), and the Kaplan-Meier survival curve was illustrated by Survival\nAnalysis package (survival 3.2-7,\nhttps://cran.r-project.org/web/packages/survival/index.html\n).\nQuantification and statistical analysis\nThe methods of quantification and statistical analysis for single-omic data\nanalysis,multi-omicdataanalysis,clinicaldataanalysisandexper imentaldata\nanalysis were carefully described in corresponding Method Details\nsubsections. Standard two-sided statistical tests used in this study included\nbut not limited to log-rank test, Fisher’s exact test, Spearman’s correlation,\nhypergeometric test, Student’s t test, and chi-square test. For categorical\nvariables vs. categorical variables, the chi-square test was used. For\ncategorical variables vs. continuous variables, the Kruskal-Wallis test was\nused to test if any of the differences between the subgroups were statistically\nsignificant. For continuous variables vs. continuous variables, Spearman\ncorrelation was used. To account for multiple-testing, the adjusted p values\nwere calculated using the BH correction. For experimental validations, each\nassay was independently repeated for ≥ 3 times, and results were present as\nmean ± standard rrror of the mean (SEM). The statistical significance of\ndifferenceswasestimated bytwo-sidedStudent’s t test.\nREFERENCES\n1. Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and\nMortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin71, 209-249 (2021).\n2. Waggoner, S.E. Cervical cancer. Lancet 361, 2217-25 (2003).\n3. Small, W., Jr. et al.Cervical cancer: A global health crisis.Cancer 123, 2404-2412 (2017).\n4. Ferlay, J. et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries\nin 2012.Eur J Cancer49, 1374-403 (2013).\n5. Bergenstrahle, L. et al. Super-resolved spatial transcriptomics by deep data fusio n. Nat\nBiotechnol (2021).\n6. Bachtiary, B. et al.Gene expression profiling in cervical cancer: an exploration of intratumor\nheterogeneity. Clin Cancer Res12, 5632-40 (2006).\n7. Hijazi, M., Smith, R., Rajeeve, V., Bessant, C. & Cutillas , P.R. Reconstructing kinase network\ntopologies from phosphoproteomics data reveals cancer-associated rewiring. Nat Biotechnol\n38, 493-502 (2020).\n8. Berry, S. et al.Analysis of multispectral imaging with the AstroPath platform informs efficacy\nof PD-1 blockade.Science 372(2021).\n9. Kather, J.N. et al. Pan-cancer image-based detection of clinically actionabl e genetic\nalterations. Nat Cancer1, 789-799 (2020).\n10. Cancer Genome Atlas Research, N. et al. Integrated genomic and molecular characterization\nof cervical cancer.Nature 543, 378-384 (2017).\n11. Kaur, M., Singh, D., Kumar, V. & Lee, H.N. MLNet: Metaheuristics-Based Lightweight Deep\nLearning Network for Cervical Cancer Diagnosis.IEEE J Biomed Health InformPP(2022).\n12. Xue, P. et al.Deep learning in image-based breast and cervical cancer detection: a systematic\nreview and meta-analysis.NPJ Digit Med5, 19 (2022).\n13. Lecler, A., Duron, L. & Soyer, P. Revolutionizing radiol ogy with GPT-based models: Current\napplications, future possibilities and limitations of ChatGPT. Diagn Interv Imaging(2023).\n14. van Dis, E.A.M., Bollen, J., Zuidema, W., van Rooij, R. & B ockting, C.L. ChatGPT: five\npriorities for research.Nature 614, 224-226 (2023).\n15. OpenAI, T. Chatgpt: Optimizing language models for dial ogue. OpenAI (2022).\n16. Floridi, L. & Chiriatti, M. GPT-3: Its nature, scope, lim its, and consequences. Minds and\nMachines 30, 681-694 (2020).\n17. Ouyang, L. et al.Training language models to follow instructions with humanfeedback. arXiv\npreprint arXiv:2203.02155(2022).\n18. Knox, W.B. & Stone, P. Augmenting reinforcement learnin g with human feedback. inICML\n2011 Workshop on New Developments in Imitation Learning (July 2011)Vol. 855 3 (2011).\n19. Bang, Y. et al. A multitask, multilingual, multimodal evaluation of chatgpt on reasoning,\nhallucination, and interactivity.arXiv preprint arXiv:2302.04023(2023).\n20. Lin, Z. et al. Evolutionary-scale prediction of atomic-level protein structure with a language\nmodel. Science 379, 1123-1130 (2023).\n21. Madani, A. et al.Large language models generate functional protein sequences across diverse\nfamilies. Nat Biotechnol(2023).\n22. Guzel, C. et al. Molecular markers for cervical cancer screening.Expert Rev Proteomics18,\n675-691 (2021).\n23. Ran, C., Sun, J., Qu, Y. & Long, N. Clinical value of MRI, serum SCCA, and CA125 levels in\nthe diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer.World J\nSurg Oncol19, 343 (2021).\n24. Wang, H., Yan, C. & Ye, H. Overexpression of MUC16 predict s favourable prognosis in\nMUC16-mutant cervical cancer related to immune response.Exp Ther Med 20, 1725-1733\n(2020).\n25. Akita, K. et al. CA125/MUC16 interacts with Src family kinases, and over-expression of its\nC-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion. Eur J Cell\nBiol 92, 257-63 (2013).\n26. Pai, P., Rachagani, S., Dhawan, P. & Batra, S.K. Mucins an d Wnt/beta-catenin signaling in\ngastrointestinal cancers: an unholy nexus.Carcinogenesis 37, 223-32 (2016).\n27. Chirravuri-Venkata, R. et al. MUC16 and TP53 family co-regulate tumor-stromal\nheterogeneity in pancreatic adenocarcinoma.Front Oncol13, 1073820 (2023).\n28. Fan, K. et al. MUC16 C terminal-induced secretion of tumor-derived IL-6 contributes to\ntumor-associated Treg enrichment in pancreatic cancer.Cancer Lett418, 167-175 (2018).\n29. Budnik, B., Levy, E., Harmange, G. & Slavov, N. SCoPE-MS: mass spectrometry of single\nmammalian cells quantifies proteome heterogeneity duringcell differentiation. Genome Biol\n19, 161 (2018).\n30. He, B. et al. Integrating spatial gene expression and breast tumour morphology via deep\nlearning. Nat Biomed Eng4, 827-834 (2020).\n31. Ojesina, A.I. et al. Landscape of genomic alterations in cervical carcinomas. Nature 506,\n371-5 (2014).\n32. Huang, J. et al. Comprehensive genomic variation profiling of cervical int raepithelial\nneoplasia and cervical cancer identifies potential targets for cervical cancer early warning.J\nMed Genet56, 186-194 (2019).\n33. Scholl, S. et al.Clinical and genetic landscape of treatment naive cervicalcancer: Alterations\nin PIK3CA and in epigenetic modulators associated with sub-optimal outcome.EBioMedicine\n43, 253-260 (2019).\n34. Zammataro, L. et al. Whole-exome sequencing of cervical carcinomas identifiesactivating\nERBB2 and PIK3CA mutations as targets for combination therapy. Proc Natl Acad Sci U S A\n116, 22730-22736 (2019).\n35. Liu, R. et al.PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.\nCell Death Dis11, 797 (2020).\n36. Zhang, J. et al. Disruption of KMT2D perturbs germinal center B cell development and\npromotes lymphomagenesis.Nat Med21, 1190-8 (2015).\n37. Wang, J. et al.Large-scale analysis of KMT2 mutations defines a distinctive molecular subset\nwith treatment implication in gastric cancer.Oncogene 40, 4894-4905 (2021).\n38. Kalu, N.N. et al. Comprehensive pharmacogenomic profiling of human\npapillomavirus-positive and -negative squamous cell carcinoma identifies sensitivity to aurora\nkinase inhibition in KMT2D mutants.Cancer Lett431, 64-72 (2018).\n39. Luke, C.J. et al. Lysoptosis is an evolutionarily conserved cell death pathway moderated by\nintracellular serpins.Commun Biol5, 47 (2022).\n40. Brown, L. et al. Desmoglein 3 promotes cancer cell migration and invasion byregulating\nactivator protein 1 and protein kinase C-dependent-Ezrin activation. Oncogene 33, 2363-74\n(2014).\n41. Spindler, V. et al. Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris\nautoantibody-induced skin blistering.J Clin Invest123, 800-11 (2013).\n42. Abula, Y., Su, Y., Tuniyazi, D. & Yi, C. Desmoglein 3 contr ibutes to tumorigenicity of\npancreatic ductal adenocarcinoma through activating Src-FAK signaling. Anim Cells Syst\n(Seoul) 25, 195-202 (2021).\n43. Yang, X. et al. Knockdown of ribosomal protein S6 suppresses proliferation, migration, and\ninvasion in epithelial ovarian cancer.J Ovarian Res13, 100 (2020).\n44. Comerford, S.A., Hinnant, E.A., Chen, Y. & Hammer, R.E. H epatic ribosomal protein S6\n(Rps6) insufficiency results in failed bile duct development and loss of hepatocyte viability; a\nribosomopathy-like phenotype that is partially p53-dependent. PLoS Genet 19, e1010595\n(2023).\n45. Poon, I.K., Patel, K.K., Davis, D.S., Parish, C.R. & Hule tt, M.D. Histidine-rich glycoprotein:\nthe Swiss Army knife of mammalian plasma.Blood 117, 2093-101 (2011).\n46. Yang, X. et al. Cervical Cancer Growth Is Regulated by a c-ABL-PLK1 Signaling Axis.\nCancer Res77, 1142-1154 (2017).\n47. Liu, X. et al. ASF1B promotes cervical cancer progression through stabilization of CDK9.\nCell Death Dis11, 705 (2020).\n48. Xu, J. et al. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53\npathway. IUBMB Life71, 347-356 (2019).\n49. Hoppe-Seyler, K., Bossler, F., Braun, J.A., Herrmann, A .L. & Hoppe-Seyler, F. The HPV\nE6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends\nMicrobiol 26, 158-168 (2018).\n50. Barone, G. et al. Human CDK18 promotes replication stress signaling and genome stability.\nNucleic Acids Res44, 8772-8785 (2016).\n51. Demeret, C., Vassetzky, Y. & Mechali, M. Chromatin remodelling and DNA replication: from\nnucleosomes to loop domains.Oncogene 20, 3086-93 (2001).\n52. Pirngruber, J., Shchebet, A. & Johnsen, S.A. Insights in to the function of the human P-TEFb\ncomponent CDK9 in the regulation of chromatin modifications and co-transcriptional mRNA\nprocessing. Cell Cycle8, 3636-42 (2009).\n53. Satija, R., Farrell, J.A., Gennert, D., Schier, A.F. & Re gev, A. Spatial reconstruction of\nsingle-cell gene expression data.Nat Biotechnol33, 495-502 (2015).\n54. Qiu, Y. et al. Post-mortem tissue proteomics reveals the pathogenesis ofmulti-organ injuries\nof COVID-19.Natl Sci Rev8, nwab143 (2021).\n55. Maacha, S. et al. Extracellular vesicles-mediated intercellular communication: roles in the\ntumor microenvironment and anti-cancer drug resistance.Mol Cancer18, 55 (2019).\n56. Weiss, F., Lauffenburger, D. & Friedl, P. Towards target ing of shared mechanisms of cancer\nmetastasis and therapy resistance.Nat Rev Cancer22, 157-173 (2022).\n57. AlMusawi, S., Ahmed, M. & Nateri, A.S. Understanding cel l-cell communication and\nsignaling in the colorectal cancer microenvironment.Clin Transl Med11, e308 (2021).\n58. Ning, J.F. et al. Myc targeted CDK18 promotes ATR and homologous recombination to\nmediate PARP inhibitor resistance in glioblastoma.Nat Commun10, 2910 (2019).\n59. Roos, W.P., Thomas, A.D. & Kaina, B. DNA damage and the balance between survival and\ndeath in cancer biology.Nat Rev Cancer16, 20-33 (2016).\n60. Glebova, K., Veiko, N., Kostyuk, S., Izhevskaya, V. & Bar anova, A. Oxidized extracellular\nDNA as a stress signal that may modify response to anticancertherapy. Cancer Lett 356,\n22-33 (2015).\n61. Remijsen, Q. et al. Neutrophil extracellular trap cell death requires both aut ophagy and\nsuperoxide generation.Cell Res21, 290-304 (2011).\n62. Teijeira, A. et al. CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors\nInduce Neutrophil Extracellular Traps that Interfere withImmune Cytotoxicity.Immunity 52,\n856-871 e8 (2020).\n63. Jin, X. et al. Phosphorylated RB Promotes Cancer Immunity by Inhibiting N F-kappaB\nActivation and PD-L1 Expression.Mol Cell73, 22-35 e6 (2019).\n64. Chen, G. et al. Exosomal PD-L1 contributes to immunosuppression and is associated with\nanti-PD-1 response.Nature 560, 382-386 (2018).\n65. Morrissey, M.A., Kern, N. & Vale, R.D. CD47 Ligation Repo sitions the Inhibitory Receptor\nSIRPA to Suppress Integrin Activation and Phagocytosis.Immunity 53, 290-302 e6 (2020).\n66. Zhang, Y. et al. Gold nanoparticles inhibit activation of cancer-associat ed fibroblasts by\ndisrupting communication from tumor and microenvironmental cells.Bioact Mater6, 326-332\n(2021).\n67. Wang, J. & Li, Y. CD36 tango in cancer: signaling pathways and functions. Theranostics 9,\n4893-4908 (2019).\n68. Zhang, B. et al.Proteogenomic characterization of human colon and rectal cancer. Nature 513,\n382-7 (2014).\n69. Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer.\nNature 534, 55-62 (2016).\n70. Chen, Y.J. et al. Proteogenomics of Non-smoking Lung Cancer in East Asia Deli neates\nMolecular Signatures of Pathogenesis and Progression.Cell 182, 226-244 e17 (2020).\n71. Clark, D.J. et al. Integrated Proteogenomic Characterization of Clear Cell R enal Cell\nCarcinoma. Cell 179, 964-983 e31 (2019).\n72. Jackson, H.W. et al. The single-cell pathology landscape of breast cancer. Nature 578,\n615-620 (2020).\n73. Song, Z. et al. Clinically applicable histopathological diagnosis system for gastric cancer\ndetection using deep learning.Nat Commun11, 4294 (2020).\n74. Coudray, N. et al. Classification and mutation prediction from non-small cell lung cancer\nhistopathology images using deep learning.Nat Med24, 1559-1567 (2018).\n75. Ehteshami Bejnordi, B. et al. Diagnostic Assessment of Deep Learning Algorithms for\nDetection of Lymph Node Metastases in Women With Breast Cancer. JAMA 318, 2199-2210\n(2017).\n76. Li, C., Guo, L., Li, S. & Hua, K. Single-cell transcriptom ics reveals the landscape of\nintra-tumoral heterogeneity and transcriptional activities of ECs in CC. Mol Ther Nucleic\nAcids 24, 682-694 (2021).\n77. Thorp, H.H. ChatGPT is fun, but not an author. Science 379, 313 (2023).\n78. Prepare for truly useful large language models. Nature Biomedical Engineering 7, 85-86\n(2023).\n79. The Lancet Digital, H. ChatGPT: friend or foe? Lancet Digit Health5, e102 (2023).\n80. Owens, B. How Nature readers are using ChatGPT. Nature 615, 20 (2023).\n81. Members, C.-N. & Partners. Database Resources of the Nat ional Genomics Data Center,\nChina National Center for Bioinformation in 2022.Nucleic Acids Res50, D27-D38 (2022).\n82. Chen, T. et al.iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids\nRes 50, D1522-D1527 (2022).\n83. Tate, J.G. et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer.Nucleic Acids Res\n47, D941-D947 (2019).\n84. Navarro Gonzalez, J. et al.The UCSC Genome Browser database: 2021 update.Nucleic Acids\nRes 49, D1046-D1057 (2021).\n85. Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform.\nBioinformatics 25, 1754-60 (2009).\n86. Ebright, R.Y. et al. Deregulation of ribosomal protein expression and translation promotes\nbreast cancer metastasis.Science 367, 1468-1473 (2020).\n87. McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing\nnext-generation DNA sequencing data.Genome Res20, 1297-303 (2010).\n88. Frankish, A. et al.Gencode 2021.Nucleic Acids Res49, D916-D923 (2021).\n89. Li, B. & Dewey, C.N. RSEM: accurate transcript quantific ation from RNA-Seq data with or\nwithout a reference genome.BMC Bioinformatics12, 323 (2011).\n90. Dobin, A. et al.STAR: ultrafast universal RNA-seq aligner.Bioinformatics 29, 15-21 (2013).\n91. The Gene Ontology, C. The Gene Ontology Resource: 20 year s and still GOing strong.\nNucleic Acids Res47, D330-D338 (2019).\n92. Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives\non genomes, pathways, diseases and drugs.Nucleic Acids Res45, D353-D361 (2017).\n93. Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micr o-purification, enrichment,\npre-fractionation and storage of peptides for proteomics u sing StageTips. Nat Protoc 2,\n1896-906 (2007).\n94. Sitaula, C. & Hossain, M.B. Attention-based VGG-16 mode l for COVID-19 chest X-ray\nimage classification.Appl Intell (Dordr), 1-14 (2020).\n95. Ning, W. et al.Open resource of clinical data from patients with pneumoniafor the prediction\nof COVID-19 outcomes via deep learning.Nat Biomed Eng4, 1197-1207 (2020).\n96. Cheung, T.K. et al. Defining the carrier proteome limit for single-cell proteo mics. Nat\nMethods 18, 76-83 (2021).\n97. Wilkerson, M.D. & Hayes, D.N. ConsensusClusterPlus: a c lass discovery tool with confidence\nassessments and item tracking.Bioinformatics 26, 1572-3 (2010).\n98. Hosny, A., Parmar, C., Quackenbush, J., Schwartz, L.H. & Aerts, H. Artificial intelligence in\nradiology. Nat Rev Cancer18, 500-510 (2018).\n99. Guo, Y. et al. iEKPD 2.0: an update with rich annotations for eukaryotic protein kinases,\nprotein phosphatases and proteins containing phosphoprotein-binding domains. Nucleic Acids\nRes 47, D344-D350 (2019).\n100. Song, C. et al. Systematic analysis of protein phosphorylation networks f rom\nphosphoproteomic data.Mol Cell Proteomics11, 1070-83 (2012).\n101. Oughtred, R. et al. The BioGRID interaction database: 2019 update.Nucleic Acids Res 47,\nD529-D541 (2019).\n102. Kotlyar, M., Pastrello, C., Malik, Z. & Jurisica, I. IID2018 update: context-specific physical\nprotein-protein interactions in human, model organisms and domesticated species. Nucleic\nAcids Res47, D581-D589 (2019).\n103. Li, T. et al. A scored human protein-protein interaction network to cata lyze genomic\ninterpretation. Nat Methods14, 61-64 (2017).\n104. Calderone, A., Castagnoli, L. & Cesareni, G. mentha: a r esource for browsing integrated\nprotein-interaction networks.Nat Methods10, 690-1 (2013).\n105. Das, J. & Yu, H. HINT: High-quality protein interactome s and their applications in\nunderstanding human disease.BMC Syst Biol6, 92 (2012).\n106. Razick, S., Magklaras, G. & Donaldson, I.M. iRefIndex: a consolidated protein interaction\ndatabase with provenance.BMC Bioinformatics9, 405 (2008).\n107. Cowley, M.J. et al. PINA v2.0: mining interactome modules.Nucleic Acids Res40, D862-5\n(2012).\n108. Han, H. et al. TRRUST v2: an expanded reference database of human and mouse\ntranscriptional regulatory interactions.Nucleic Acids Res46, D380-D386 (2018).\n109. Schaefer, U., Schmeier, S. & Bajic, V.B. TcoF-DB: dragon database for human transcription\nco-factors and transcription factor interacting proteins. Nucleic Acids Res39, D106-10 (2011).\n110. Hornbeck, P.V . et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic\nAcids Res43, D512-20 (2015).\n\nFigure Legends\nFigure 1. The workflow and an example of utilizing LLMs.\n(A) LLMs for interpretation, reasoning and finding new insights. (B) A\nmulti-dimensional characterization of SCC by integration of WS Is and\nmulti-omic profiles including proteomics, phosphoproteomics, e xomics,\ntranscriptomics,andSCSP. (C) Three querying modules iniKLPstrategy.(D-F)\nAn example of utilizing LLMs for in interpretation and reasoni ng. LLMs\ninterpret the molecular function and pathways of CA125 (D). By\ncross-disciplinary reasoning, ChatGPT established a potential rel ation\nbetween CA125 expression in tumor and corresponding cell nuclei\nmorphology (E, F).\n\nFigure 2. The genomic alterations and HPV status of SCC.\n(A) ThemutationlandscapeofSCCcohort.Genomicalterationsmore than5%\nin population were presented as FMGs. (B) The comparison of mutation\nfrequencies of FMGs identified in this study to previous repor ts. (C-H)\nChatGPTinterpretationofknown FMGs inSCC.\n\nFigure 3. Molecular subtyping of SCC patients.\n(A) The consistency learning architecture of subtyping module that included 3\nsteps,CFembedding,omicdataembeddingandrandomizeditera tiontoreach\nan optimal consistency. Image features of WSIs further realized mutual\ninterpretable subtyping of SCC. (B) The subtyping of patients based on\nproteomic data, as well as the correlation between proteomicsubtypes and\nother omics-based subtypes and clinicopathologic features. In theheatmap,\neach column represented a patient and each row denoted a protein.For each\nrow, the expression levels of a protein were normalized using the z-score\nmethod.(C) Thedegreeofimmuneinfiltrationin3proteomic subtypes. (D) HE\nrepresentative tiles of high and low immune-infiltration samples. (E) ChatGPT\ninterpretationofDSG3andRPS6.\n\nFigure 4. Identification of potential biomarker proteins in SCC.\n(A) To identify potential tumor- and subtype-specific protein biomarkers, we\ndeveloped deepCMD-Marker that included 3 steps, including RGC for random\ngeneration of candidate combinations, CMA for calculation of themaximum\naccuracy for each combination, and FCD for final combination determination.\n(B) ThemeanAUCvaluesofthetop10combinationsspecificforSCCtu mors,\nand proteomic subtypes S-I, S-II, and S-III.(C,D) The representative images\n(upper panel) and quantification (bottom panel) of IHC analysis of DHCR24,\nEPCAM, GBP1 and GINS3 (PSF3) in 25 SCC primary tumor samples and 9\nnormal cervix. Scale bar, 50 μm. An unpaired t test was performed for\nstatistical analysis.(E) The heatmap showing different expression patterns of\nHRG,SEPTINS,SERPINA4andPLGinSCCtumors.Thecorrelationb etween\nthe expression of HRG and SEPTINS / SERPINA4 / PLG were analyzed with\nSpearman’s correlation analysis, r = 0.71, 0.50 and 0.43 respectively.(F) The\nrepresentative images of IHC analysis showing HGR protein expressi on\nheterogeneity among SCC tumor samples. Scale bar, 50μm. (G) The\nhistogram showing different HRG protein expression levels measured by IHC\nscore among FIGO I~III stages in cohort 2 of 160 patients. One-way ANOVA\nwith Bonferroni post hoc test was performed for statistical analysis. (H) The\nKaplan–Meier survival curves showing HRG protein expression level was\nnegatively correlated with the OS outcome in cohort 3 of 115 SCC samples.A\nlog-ranktestwasperformedforstatisticalanalysis.* p <0.05,** p <0.01,*** p <\n0.001. (I) HE representative tiles and corresponding image feature “StDev\nFormFactor” of high and low HRG expressed samples. (J) Reasoning\nconfidence before and after provided experimental results for potential\nbiomarkerproteins.\n\nFigure 5. Identification of actionable PKs in SCC.\n(A) We developed deepCMD-Kinase that included 3 steps, including\nre-construction of ssKSPN using the software package of iGPS100, merging\nsamples to maximize the substrate p-site intensities, and prioritization of final\nactionablePKsbasedonastatisticalanalysisofthechangesintheir substrate\np-sites. (B) The histogram showing growth inhibition effects of a panel of\ninhibitors (50 nM) as indicated in Siha cells after 72h treatment. (C,D) The\nrepresentative results of cell proliferation assay in HeLa cells while CDK18,\nCDK9 and PLK1 expression were diminished by siRNA. Each sample was\nassayed in quintuplicates in 96-well plate. Cell viability wasmeasured with\nCCK8 kit at OD = 450 nm every 48h consecutively (C). The representative\nimages of crystal violet staining of HeLa and SiHa cell density 8 d\npost-transfection was shown (D).(E) The tumor growth curves of HeLa cell\nline-derived xenograft and three cervical cancer PDXs after AZD 4573\ntreatment (n = 5 or 6). Black arrows indicate the starting point of drug\nadministration. One-way ANOVAwith Bonferroni post hoc test was performed\nfor statistical analysis.(F) The western blot analysis of indicated proteins in\nparental HeLa cells and cell clones with CDK18 depletion by CRISPR-Cas9.\n(G) The cell proliferation assay of CDK18 knock-out HeLa cells. Each sample\nwasassayedinquintuplicatesin96-wellplate.Cellviability wasmeasuredwith\nCCK8kitatOD=450nmevery48hconsecutively. (H) Thehistogramshowing\nrelative expression levels of HPV E6 and E7 transcripts in CDK18 knock-out\nHeLa cells by qPCR. One-way ANOVA with Bonferroni post hoc test was\nperformed for statistical analysis. (I) The tumor growth curves and\nphotography of xenografts implanted with parental and CDK18 knock-out\nHeLa cells. In each mouse, Parental HeLa cells were injected into the right\nflank while CDK18 knock-out HeLa cells into the left flank of nudemice as\nindicated by the dashed circle in respective colors (n = 4). (J) HE\nrepresentative tiles and corresponding image feature “Granularity” of high and\nlow CDK18 expressed samples.(K) The kinase activity of CDK18 in S-I, S-II\nandS-III.\n\nFigure 6. The single-cell heterogeneity landscape of SCC.\n(A) The workflow of SCSPmodule.The preprocessing steps included imaging\nclustering of 29 cell states, deconvolution of the spatial proteomes (3,541\nproteins) of the 29 single-cell states, estimation of the proportions of the 29\nsingle-cell states in SCC patients, deconvolution of the remaining proteomes\n(10,235 proteins) of the 29 single-cell states, and optimizationof immune cell\nsubtypes. (B) Expression heatmap of 29 cell states markers. Values were\nnormalized with min-max normalization.(C) The expressionof classic immune\nmarkers CD4, smooth muscle actin marker and CDK18 in serial-section either\nby IHC or deepCMD-SCSP prediction. Pearson correlation was calculated to\nanalyze the consistency of the predicted focal and IHC positive regions. (D)\nThe 3D reconstruction and visualization of CDK18 highly expressedcells and\nCD8+ T cell in an SCC tumor at single-cell resolution.(E) Overview of 29\noverlaid single-cell nuclear-scale images. (F-H) Image features associated\nwithoverlaidsingle-cell nuclear-scaleimages,including“Norma lizedMoment”,\n“AngularSecondMoment” and “ConvexArea”. The image feature distributions\nweredisplayed inbarplots.\n\nFigure 7. The educated signal web of SCC single-cell states.\n(A) The 71 SCC related molecular from 10 cell states were connected by\nknowledge from PPI databases and ChatGPT answers. The 35.4%\nconnections contained direction information provided by ChatG PT. The\nmolecularwere marked if they were DEPor DPPin omics data.The reasoned\ncell-cell interaction models were shown in this signal web. (B) The statistic of\nedges within the signal web, including PPI, ChatGPT association a nd\nChatGPT PPI. (C) The western blot analysis of CDK18 depletion and PD-L1\nexpression. (D) The wordcloud of answers from ChatGPT within thesignal\nweb.\nSupplementary Files\nThis is a list of supplementary \u0000les associated with this preprint. Click to download.\nTableS1.xlsx\nTableS2.xlsx\nTableS31.xlsx\nTableS32.xlsx\nTableS4.xlsx\nTableS5.xlsx\nTableS6.xlsx\nSCCSupplement.pdf",
  "topic": "Cervical cancer",
  "concepts": [
    {
      "name": "Cervical cancer",
      "score": 0.5783930420875549
    },
    {
      "name": "Cancer",
      "score": 0.4415808320045471
    },
    {
      "name": "Computational biology",
      "score": 0.37899765372276306
    },
    {
      "name": "Medicine",
      "score": 0.37287354469299316
    },
    {
      "name": "Computer science",
      "score": 0.350094735622406
    },
    {
      "name": "Biology",
      "score": 0.23644602298736572
    },
    {
      "name": "Internal medicine",
      "score": 0.19173556566238403
    }
  ],
  "institutions": [
    {
      "id": "https://openalex.org/I47720641",
      "name": "Huazhong University of Science and Technology",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I4210160344",
      "name": "Tongji Hospital",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I881766915",
      "name": "Nanjing University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I4210161528",
      "name": "Qilu Hospital of Shandong University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I126520041",
      "name": "University of Science and Technology of China",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I4210154480",
      "name": "Chongqing Cancer Hospital",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I158842170",
      "name": "Chongqing University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I4210137217",
      "name": "Women's Hospital, School of Medicine, Zhejiang University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I4391768003",
      "name": "State Key Laboratory of Biotherapy",
      "country": null
    },
    {
      "id": "https://openalex.org/I24185976",
      "name": "Sichuan University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I157773358",
      "name": "Sun Yat-sen University",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I4210146711",
      "name": "Sun Yat-sen University Cancer Center",
      "country": "CN"
    },
    {
      "id": "https://openalex.org/I165690674",
      "name": "Oregon Health & Science University",
      "country": "US"
    }
  ],
  "cited_by": 1
}